<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>w86899dfdef14a.htm
<DESCRIPTION>ENTREMED, INC. PROXY STATEMENT
<TEXT>
<HTML>
<HEAD>
<TITLE>def14a</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<P align="center">
<B><FONT size="2">SCHEDULE 14A</FONT></B>

<DIV align="center">
<B><FONT size="2">(Rule 14a-101)</FONT></B>
</DIV>

<P align="center">
<B><FONT size="2">INFORMATION REQUIRED IN PROXY
STATEMENT</FONT></B>

<P align="center">
<B><FONT size="2">SCHEDULE 14A INFORMATION</FONT></B>

<DIV align="center">
<B><FONT size="2">Proxy Statement Pursuant to Section 14(a) of
the Securities</FONT></B>
</DIV>

<DIV align="center">
<B><FONT size="2">Exchange Act of 1934 (Amendment
No.&nbsp;&nbsp;)</FONT></B>
</DIV>

<CENTER>
<TABLE width="100%" align="center" cellspacing="0" cellpadding="0" border="0">

<TR>
    <TD width="51%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="46%"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom" bgcolor="#EEEEEE">
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">Filed by the
    Registrant<FONT face="wingdings">&#254;</FONT>
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">Filed by a Party other than the
    Registrant<FONT face="wingdings">&#111;</FONT>
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom" bgcolor="#EEEEEE">
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">Check the appropriate box:
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom" bgcolor="#EEEEEE">
    <TD colspan="3"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2"><FONT face="wingdings">&#111;</FONT>&nbsp;Preliminary
    Proxy Statement
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top">
    <FONT size="2"><FONT face="wingdings">&#111;</FONT>&nbsp;Confidential,
    for Use of the Commission Only (as permitted by
    Rule&nbsp;14a-6(e)(2))
    </FONT></TD>
</TR>

<TR>
    <TD colspan="3"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom" bgcolor="#EEEEEE">
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2"><FONT face="wingdings">&#254;</FONT>&nbsp;Definitive
    Proxy Statement
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom" bgcolor="#EEEEEE">
    <TD colspan="3"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2"><FONT face="wingdings">&#111;</FONT>&nbsp;Definitive
    Additional Materials
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom" bgcolor="#EEEEEE">
    <TD colspan="3" align="left" valign="top">
    <FONT size="2"><FONT face="wingdings">&#111;</FONT>&nbsp;Soliciting
    Material Pursuant to Rule 14a-11(c) or Rule 14a-12
    </FONT></TD>
</TR>

</TABLE>
</CENTER>

<P align="center">
<FONT size="2">ENTREMED, INC.
</FONT>

<DIV align="left">
<HR size="1" width="100%" align="left" noshade>
</DIV>

<DIV align="center">
<FONT size="2">(Name of Registrant as Specified in Its Charter)
</FONT>
</DIV>

<P align="left">
<HR size="1" width="100%" align="left" noshade>

<DIV align="center">
<FONT size="2">(Name of Person(s) Filing Proxy Statement if
other than the Registrant)
</FONT>
</DIV>

<P align="left">
<FONT size="2">Payment of Filing Fee (Check the appropriate box):
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT face="wingdings">&#254;</FONT><FONT size="2">&nbsp;No fee
required.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT face="wingdings">&#111;</FONT><FONT size="2">&nbsp;Fee
computed on table below per Exchange Act Rules 14a-6(i)(1) and
0-11.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">(1)&nbsp;Title of each class of securities to
which transaction applies:
</FONT>

<P align="left">
<HR size="1" width="100%" align="left" noshade>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">(2)&nbsp;Aggregate number of securities to which
transaction applies:
</FONT>

<P align="left">
<HR size="1" width="100%" align="left" noshade>
<P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="3%"></TD>
    <TD width="4%"></TD>
    <TD width="93%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD><FONT size="2">(3)&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">Per unit price or other underlying value of
    transaction computed pursuant to Exchange Act Rule&nbsp;0-11
    (Set forth the amount on which the filing fee is calculated and
    state how it was determined):
    </FONT></TD>
</TR>

</TABLE>

<P align="left">
<HR size="1" width="100%" align="left" noshade>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">(4)&nbsp;Proposed maximum aggregate value of
transaction:
</FONT>

<P align="left">
<HR size="1" width="100%" align="left" noshade>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">(5)&nbsp;Total fee paid:
</FONT>

<P align="left">
<HR size="1" width="100%" align="left" noshade>
<P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="3%"></TD>
    <TD width="3%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD><FONT face="wingdings">&#111;</FONT><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">Fee paid previously with preliminary materials.
    </FONT></TD>
</TR>

<TR>
    <TD>&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD><FONT face="wingdings">&#111;</FONT><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">Check box if any part of the fee is offset as
    provided by Exchange Act Rule&nbsp;0-11(a)(2) and identify the
    filing for which the offsetting fee was paid previously.
    Identify the previous filing by registration statement number,
    or the form or schedule and the date of its filing.
    </FONT></TD>
</TR>

</TABLE>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">(1)&nbsp;Amount previously paid:
</FONT>

<P align="left">
<HR size="1" width="100%" align="left" noshade>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">(2)&nbsp;Form, schedule or registration statement
no.:
</FONT>

<P align="left">
<HR size="1" width="100%" align="left" noshade>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">(3)&nbsp;Filing party:
</FONT>

<P align="left">
<HR size="1" width="100%" align="left" noshade>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">(4)&nbsp;Date filed:
</FONT>

<P align="left">
<HR size="1" width="100%" align="left" noshade>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV align="center">
<IMG src="w86899dfentremlk.gif" alt="(ENTREMED LOGO)">
</DIV>

<DIV>&nbsp;</DIV>

<!-- link1 "ENTREMED, INC." -->

<DIV align="center">
<B><FONT size="4">ENTREMED, INC.</FONT></B>
</DIV>

<DIV>&nbsp;</DIV>

<!-- link1 "NOTICE OF ANNUAL MEETING OF STOCKHOLDERS" -->

<P align="center">
<B>NOTICE OF ANNUAL MEETING OF STOCKHOLDERS</B>

<P align="center">
<B>To be held June&nbsp;18, 2003</B>

<P align="left">
<FONT size="2">To Our Stockholders:
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Notice is hereby given that the annual meeting of
the stockholders of EntreMed, Inc. (the &#147;Company&#148;)
will be held on June&nbsp;18, 2003, at 10:00&nbsp;a.m. local
time, at the Gaithersburg Marriott Washington Center, 9751
Washingtonian Boulevard, Gaithersburg, Maryland 20878 (the
&#147;Annual Meeting&#148;). The Annual Meeting is called for
the following purposes:
</FONT>
<P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="3%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <FONT size="2">1.&nbsp;To elect two directors to a term of three
    years, or until their successors have been elected and qualified;
    </FONT></TD>
</TR>

<TR>
    <TD>&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <FONT size="2">2.&nbsp;To approve amendments to the
    Company&#146;s 2001 Long-term Incentive Plan increasing from
    3,250,000 to 4,250,000 the number of shares of Common Stock
    reserved for issuance thereunder;
    </FONT></TD>
</TR>

<TR>
    <TD>&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <FONT size="2">3.&nbsp;To approve and ratify the appointment of
    Ernst &#38; Young LLP as the independent auditors of the
    Company; and
    </FONT></TD>
</TR>

<TR>
    <TD>&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    <FONT size="2">4.&nbsp;To consider and take action upon such
    other matters as may properly come before the Annual Meeting or
    any postponement or adjournment thereof.
    </FONT></TD>
</TR>

</TABLE>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The Board of Directors has fixed April&nbsp;28,
2003 as the record date for the determination of stockholders
entitled to notice of, and to vote at, the Annual Meeting. Only
stockholders of record at the close of business on that date
will be entitled to notice of, and to vote at, the Annual
Meeting.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">You are cordially invited to attend the Annual
Meeting. Whether you expect to attend, we request that you sign,
date and return the enclosed proxy promptly. Stockholders who
execute proxies retain the right to revoke them at any time
prior to the voting. A return envelope, which requires no
postage, if mailed in the United States is enclosed for your
convenience.
</FONT>
<P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="38%"></TD>
    <TD width="62%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    <FONT size="2">By Order of the Board of Directors,
    </FONT></TD>
</TR>

<TR>
    <TD>&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    <BR>
    <FONT size="2"> Michael Tarnow
    </FONT></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    <I><FONT size="2">Chairman of the Board</FONT></I></TD>
</TR>

</TABLE>

<P align="left">
<FONT size="2">May&nbsp;23, 2003
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<!-- link1 "Common Questions Regarding Proxies" -->

<P align="center">
<B><FONT size="2">Common Questions Regarding Proxies</FONT></B>

<P align="left">
<B><FONT size="2">Q: Why am I receiving this Proxy Statement and
proxy card?</FONT></B>

<P align="left">
<B><FONT size="2">A: </FONT></B><FONT size="2">You are receiving
a Proxy Statement and proxy card from us because you own shares
of Common Stock of the Company. This Proxy Statement describes
issues on which we would like you, as a stockholder, to vote. It
also gives you information on these issues so that you can make
an informed decision.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">When you sign the proxy card, you appoint Michael
Tarnow and James D. Johnson Ph.D. as your representatives at the
meeting. Mr.&nbsp;Tarnow and Dr. Johnson will vote your shares
at the meeting as you have instructed them on the proxy card.
This way, your shares will be voted whether you attend the
Annual Meeting. Even if you plan to attend the meeting, it is a
good idea to complete, sign and return your proxy card in
advance of the meeting just in case your plans change. You can
always decide to vote in person.
</FONT>

<P align="left">
<B><FONT size="2">Q: What is the record date?</FONT></B>

<P align="left">
<B><FONT size="2">A: </FONT></B><FONT size="2">The record date
is set for April&nbsp;28, 2003. Only holders of Common Stock and
the Series&nbsp;A Convertible Preferred Stock (which votes on an
as-converted basis with the Common Stock) of record as of the
close of business on this date will be entitled to vote at the
Annual Meeting.
</FONT>

<P align="left">
<B><FONT size="2">Q: How many shares are outstanding?</FONT></B>

<P align="left">
<B><FONT size="2">A: </FONT></B><FONT size="2">As of the record
date, the Company had 28,528,566 shares of Common Stock
outstanding.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">In addition, as discussed in greater detail in
the Proxy Statement, Celgene Corporation owns 3,350,000 shares
of our Series&nbsp;A Convertible Preferred Stock (the
&#147;Convertible Preferred Stock&#148;). Celgene has the right
to one vote for each share of Common Stock into which its shares
of Convertible Preferred Stock are convertible, currently
16,750,000 shares. This means that at the Annual Meeting,
Celgene will be allowed to vote as if it owned 16,750,000 shares
of our Common Stock. On a pro-forma basis (assuming the
conversion of the Convertible Preferred Stock), this represents
approximately 37% of the shares of our Common Stock entitled to
vote at the meeting. Therefore, we expect that Celgene&#146;s
vote will determine the outcome on each proposal.
</FONT>

<P align="left">
<B><FONT size="2">Q: What am I voting on?</FONT></B>

<P align="left">
<B><FONT size="2">A: </FONT></B><FONT size="2">You are being
asked to vote on the election of three directors to the terms
described in the Proxy Statement, the approval of an amendment
to the Company&#146;s 2001 Long-Term Incentive Plan and the
approval and ratification of Ernst &#38; Young LLP as the
independent auditors of the Company.
</FONT>

<P align="left">
<B><FONT size="2">Q: How do I vote?</FONT></B>

<P align="left">
<B><FONT size="2">A: </FONT></B><FONT size="2">You may either
vote by mail or in person at the Annual Meeting. To vote by
mail, please sign your proxy card and mail it in the enclosed,
prepaid and addressed envelope. If you mark your voting
instructions on the proxy card, your shares will be voted in
accordance with your instructions. If you return a signed card
but do not provide voting instructions, your shares will be
voted based on the recommendations of the Board of Directors. We
will pass out written ballots to anyone who wants to vote at the
Annual Meeting. If you hold your shares through a brokerage
account and do not have a physical shares certificate, you must
request a legal proxy from your stockbroker in order to vote at
the Annual Meeting.
</FONT>

<P align="left">
<B><FONT size="2">Q: What does it mean if I receive more than
one proxy card?</FONT></B>

<P align="left">
<B><FONT size="2">A: </FONT></B><FONT size="2">It means that you
have multiple accounts at the transfer agent and/or with
stockbrokers. Please sign and return all proxy cards to ensure
that all your shares are voted.
</FONT>

<P align="left">
<B><FONT size="2">Q: How many votes do you need to hold the
meeting?</FONT></B>

<P align="left">
<B><FONT size="2">A: </FONT></B><FONT size="2">A majority of the
Company&#146;s outstanding shares of Common Stock (on an
as-converted basis) as of the record date must be present at the
meeting in order to hold the Annual Meeting and conduct
business. This is called a quorum.
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<P align="left">
<B><FONT size="2">Q: What if I abstain from voting?</FONT></B>

<P align="left">
<B><FONT size="2">A: </FONT></B><FONT size="2">Abstentions with
respect to a proposal are counted for purposes of establishing a
quorum. If a quorum is present, abstentions have no effect on
the outcome of the vote for directors, but will count as a vote
against the change to the 2001 Long-Term Incentive Plan and the
ratification of the Company&#146;s independent auditors.
</FONT>

<P align="left">
<B><FONT size="2">Q: How many votes must the nominees have to be
elected?</FONT></B>

<P align="left">
<B><FONT size="2">A: </FONT></B><FONT size="2">In order for a
director to be elected, he or she must receive a plurality of
the shares voted. In other words, the two nominees to receive
the greatest number of votes cast will be elected.
</FONT>

<P align="left">
<B><FONT size="2">Q: How are votes counted?</FONT></B>

<P align="left">
<B><FONT size="2">A: </FONT></B><FONT size="2">Voting results
will be tabulated and certified by our Inspector of Elections.
</FONT>

<P align="left">
<B><FONT size="2">Q: Where can I find the voting results of the
Annual Meeting?</FONT></B>

<P align="left">
<B><FONT size="2">A: </FONT></B><FONT size="2">We will announce
the voting results at the Annual Meeting. We will also publish
the results in our quarterly report on Form&nbsp;10-Q for the
second quarter of 2003. We will file that report with the
Securities and Exchange Commission (&#147;SEC&#148;), and you
can get a copy by:
</FONT>
<P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD width="96%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD><FONT size="2">&#149;&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">contacting EntreMed corporate offices via phone
    (240) 864-2600; or email at christopherc@entremed.com;
    </FONT></TD>
</TR>

<TR>
    <TD>&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD><FONT size="2">&#149;&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">through the SEC&#146;s EDGAR system at
    <I>www.sec.gov </I>or by contacting the SEC&#146;s public
    reference room.
    </FONT></TD>
</TR>

</TABLE>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<!-- link1 "ENTREMED, INC. 9640 Medical Center Drive Rockville, Maryland 20850 (240) 864-2600" -->

<P align="center">
<B><FONT size="4">ENTREMED, INC.</FONT></B>

<DIV align="center">
<B><FONT size="2">9640 Medical Center Drive</FONT></B>
</DIV>

<DIV align="center">
<B><FONT size="2">Rockville, Maryland 20850</FONT></B>
</DIV>

<DIV align="center">
<B><FONT size="2">(240)&nbsp;864-2600</FONT></B>
</DIV>

<P align="center">
<B><FONT size="4">PROXY STATEMENT</FONT></B>

<P align="center">
<B>ANNUAL MEETING OF STOCKHOLDERS</B>

<DIV align="center">
<B><FONT size="2">To be held June&nbsp;18, 2003</FONT></B>
</DIV>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">This Proxy Statement is furnished in connection
with the solicitation of proxies by the Board of Directors of
EntreMed, Inc., a Delaware corporation (the
&#147;Company&#148;), the principal executive offices of which
are located at 9640 Medical Center Drive, Rockville, Maryland
20850, for the Annual Meeting of Stockholders to be held at the
Gaithersburg Marriott Washington Center, 9751 Washingtonian
Boulevard, Gaithersburg, Maryland 20878 on June&nbsp;18, 2003,
at 10:00&nbsp;a.m. (local time) and for any postponement, or
adjournments thereof (the &#147;Annual Meeting&#148;), for the
purposes set forth in the accompanying Notice of Annual Meeting
of Stockholders. Any stockholder giving such a proxy has the
power to revoke it at any time before it is voted. Written
notice of such revocation should be forwarded directly to the
Secretary of the Company at the above stated address. Attendance
at the Annual Meeting will not have the effect of revoking the
proxy unless such written notice is given or the stockholder
votes by ballot at the Annual Meeting.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">If the enclosed proxy is properly executed and
returned, the shares represented thereby will be voted in
accordance with the directions thereon and otherwise in
accordance with the judgment of the persons designated as
proxies. Any proxy on which no direction is specified will be
voted in favor of the actions described in this Proxy Statement,
including the election of the director nominees set forth under
the caption &#147;Election of Directors&#148;, the approval of
the amendment to the 2001 Long-Term Incentive Plan (the
&#147;2001 Plan&#148;), and the ratification of the appointment
of Ernst &#38; Young LLP as the independent auditors of the
Company.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The approximate date on which this Proxy
Statement and the accompanying form of proxy will first be
mailed or given to the Company&#146;s stockholders is
May&nbsp;23, 2003.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Your vote is important. Accordingly, we urge you
to sign and return the accompanying proxy card whether or not
you plan to attend the Annual Meeting. If you do attend, you may
vote by ballot at the Annual Meeting, thereby canceling any
proxy previously given.
</FONT>

<!-- link1 "VOTING SECURITIES" -->

<P align="center">
<B><FONT size="2">VOTING SECURITIES</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Holders of record of shares of the Company&#146;s
common stock, par value $.01 per share (the &#147;Common
Stock&#148;), and of the Company&#146;s Series&nbsp;A
convertible preferred stock, $1.00 par value per share (the
&#147;Convertible Preferred Stock&#148;) as of the close of
business on April&nbsp;28, 2003 (the &#147;Record Date&#148;),
are entitled to notice of and to vote at the Annual Meeting on
all matters. On the Record Date, the Company had outstanding
28,528,566 shares of Common Stock and 3,350,000 shares of
Convertible Preferred Stock convertible into 16,750,000 shares
of Common Stock. Each outstanding share of Common Stock is
entitled to one vote upon all matters to be acted upon at the
Annual Meeting. Each outstanding share of Convertible Preferred
Stock is entitled to one vote for each share of Common Stock
that the Convertible Preferred Stock is convertible into,
currently five. A majority of the outstanding shares of Common
Stock, assuming the conversion of the Convertible Preferred
Stock (together, the &#147;Shares&#148;), entitled to vote on
any matter and represented at the Annual Meeting, in person or
by proxy, shall constitute a quorum.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Abstentions and broker non-votes are counted for
purposes of determining the presence or absence of a quorum for
the transaction of business. Assuming a quorum is present, the
affirmative vote of a plurality of the Shares cast in person or
represented by proxy at the Annual Meeting and entitled to vote
on the election of directors is required to elect the director
nominees. Abstentions and broker non-votes will not affect the
outcome of the election of directors. The affirmative vote of a
majority of the Shares cast in person or
</FONT>

<P align="center">

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV align="left">
<FONT size="2">represented by proxy at the Annual Meeting and
entitled to vote on the matter is necessary to approve the
amendment to the 2001 Plan and to ratify the appointment of
Ernst &#38; Young LLP as the independent auditors of the
Company. Thus, an abstention from voting on these proposals will
have the same legal effect as a vote &#147;against&#148; these
proposals, even though the stockholder may interpret such action
differently. Broker non-votes will not be counted for any
purpose in determining whether these proposals have been
approved and will not affect the outcome of the vote on these
proposals.
</FONT>
</DIV>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Celgene Corporation owns all of the 3,350,000
shares of our Convertible Preferred Stock. The terms of the
Convertible Preferred Stock provide that the holders of the
Convertible Preferred Stock have the right to one vote for each
share of Common Stock into which such shares of Convertible
Preferred Stock could then be converted. Currently, each share
of the Convertible Preferred Stock held by Celgene is
convertible into five shares of Common Stock, for an aggregate
of 16,750,000 shares of Common Stock. This means that at the
Annual Meeting, Celgene will be permitted to vote as if it owned
16,750,000 shares of our Common Stock. On a pro-forma basis
(assuming the conversion of the Preferred Stock), this
represents 37% of the shares of our Common Stock entitled to
vote at the meeting. Therefore, we expect that Celgene&#146;s
vote will determine the outcome on each proposal.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The Company is not currently aware of any matters
that will be brought before the Annual Meeting (other than
procedural matters) that are not referred to in the enclosed
Notice of Annual Meeting.
</FONT>

<!-- link1 "SECURITY OWNERSHIP OF MANAGEMENT AND CERTAIN BENEFICIAL HOLDERS" -->

<P align="center">
<B><FONT size="2">SECURITY OWNERSHIP OF MANAGEMENT AND CERTAIN
BENEFICIAL HOLDERS</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The following table sets forth, as of
April&nbsp;23, 2003, certain information concerning stock
ownership of all persons known by us to own beneficially more
than 5% of our Common Stock, $.01 par value per share, as well
as each director or director nominee, each executive officer
named under &#147;Executive Compensation and Other Matters&#148;
and all of our directors and executive officers as a group.
</FONT>

<CENTER>
<TABLE width="100%" align="center" cellspacing="0" cellpadding="0" border="0">

<TR>
    <TD width="59%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="12%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="1%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="12%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="5%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="1%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="4%"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
    <TD></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">Amount and Nature of</FONT></B></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">Percentage</FONT></B></TD>
</TR>

<TR>
    <TD align="center" nowrap><B><FONT size="2">Name of Beneficial Owner (1)</FONT></B></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">Beneficial Ownership(1)</FONT></B></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">of Class</FONT></B></TD>
</TR>

<TR>
    <TD align="center" nowrap><HR size="1" noshade></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><HR size="1" noshade></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><HR size="1" noshade></TD>
</TR>

<TR valign="bottom" bgcolor="#EEEEEE">
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">Michael M. Tarnow
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">62,500</FONT></TD>
    <TD align="left" valign="top" nowrap><FONT size="2">(2)</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">*</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">John W. Holaday, Ph.D.&nbsp;</FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">2,225,501</FONT></TD>
    <TD align="left" valign="top" nowrap><FONT size="2">(3)</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">8.61</FONT></TD>
    <TD align="left" valign="top" nowrap><FONT size="2">%</FONT></TD>
</TR>

<TR valign="bottom" bgcolor="#EEEEEE">
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">Edward R. Gubish, Ph.D.&nbsp;</FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">682,001</FONT></TD>
    <TD align="left" valign="top" nowrap><FONT size="2">(4)</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">2.72</FONT></TD>
    <TD align="left" valign="top" nowrap><FONT size="2">%</FONT></TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">Donald S. Brooks
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">281,001</FONT></TD>
    <TD align="left" valign="top" nowrap><FONT size="2">(5)</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">1.14</FONT></TD>
    <TD align="left" valign="top" nowrap><FONT size="2">%</FONT></TD>
</TR>

<TR valign="bottom" bgcolor="#EEEEEE">
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">James D. Johnson Ph.D., J.D.&nbsp;</FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">301,168</FONT></TD>
    <TD align="left" valign="top" nowrap><FONT size="2">(6)</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">*</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">Peter S. Knight
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">75,000</FONT></TD>
    <TD align="left" valign="top" nowrap><FONT size="2">(7)</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">*</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom" bgcolor="#EEEEEE">
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">Jerry Finkelstein
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">165,000</FONT></TD>
    <TD align="left" valign="top" nowrap><FONT size="2">(8)</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">*</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">Jennie C. Hunter-Cevera, Ph.D.&nbsp;</FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">45,000</FONT></TD>
    <TD align="left" valign="top" nowrap><FONT size="2">(9)</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">*</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom" bgcolor="#EEEEEE">
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">Mark C. M. Randall
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">163,001</FONT></TD>
    <TD align="left" valign="top" nowrap><FONT size="2">(10)</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">*</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">Wendell M. Starke
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">922,711</FONT></TD>
    <TD align="left" valign="top" nowrap><FONT size="2">(11)</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">3.72</FONT></TD>
    <TD align="left" valign="top" nowrap><FONT size="2">%</FONT></TD>
</TR>

<TR valign="bottom" bgcolor="#EEEEEE">
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">Dane R. Saglio
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">32,250</FONT></TD>
    <TD align="left" valign="top" nowrap><FONT size="2">(12)</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">*</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">Neil J. Campbell
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">197,500</FONT></TD>
    <TD align="left" valign="top" nowrap><FONT size="2">(13)</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">*</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom" bgcolor="#EEEEEE">
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">All executive officers and directors as a group
    (12 persons)
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">5,069,465</FONT></TD>
    <TD align="left" valign="top" nowrap><FONT size="2">(14)</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">18.03</FONT></TD>
    <TD align="left" valign="top" nowrap><FONT size="2">%</FONT></TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">More Than 5% Beneficial Owner
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">23,750,000</FONT></TD>
    <TD align="left" valign="top" nowrap><FONT size="2">(15)</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">49.31</FONT></TD>
    <TD align="left" valign="top" nowrap><FONT size="2">%</FONT></TD>
</TR>

<TR valign="bottom" bgcolor="#EEEEEE">
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">Celgene Corporation<BR>
    7 Powder Horn Drive<BR>
    Warren, N.J. 07059
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

</TABLE>
</CENTER>

<DIV align="left">
<HR size="1" width="18%" align="left" noshade>
</DIV>
<P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="1%"></TD>
    <TD width="2%"></TD>
    <TD width="97%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD><FONT size="2">*</FONT></TD>
    <TD align="left">
    <FONT size="2">Less than 1%
    </FONT></TD>
</TR>

</TABLE>
<P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="1%"></TD>
    <TD width="4%"></TD>
    <TD width="95%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD><FONT size="2">(1)&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">Beneficial ownership is defined in accordance
    with the rules of the Securities and Exchange Commission
    (&#147;SEC&#148;) and generally means the power to vote and/or
    to dispose of the securities regardless of any economic interest
    therein.
    </FONT></TD>
</TR>

<TR>
    <TD>&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD><FONT size="2">(2)&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">Includes 62,500 shares issuable upon exercise of
    options and warrants which are exercisable within 60&nbsp;days
    and 187,500 shares issuable upon exercise of options not
    exercisable within 60 days.
    </FONT></TD>
</TR>

</TABLE>

<P align="center"><FONT size="2">2
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="1%"></TD>
    <TD width="4%"></TD>
    <TD width="95%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD><FONT size="2">(3)&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">Includes 1,417,069 shares issuable upon exercise
    of options and warrants which are exercisable within
    60&nbsp;days and 126,666 shares held by a limited partnership of
    which Dr.&nbsp;Holaday is the general partner. Does not include
    50,000 shares issuable upon exercise of warrants not exercisable
    within 60&nbsp;days.
    </FONT></TD>
</TR>

<TR>
    <TD>&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD><FONT size="2">(4)&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">Includes 672,001 shares issuable upon exercise of
    options that are exercisable within 60&nbsp;days.
    </FONT></TD>
</TR>

<TR>
    <TD>&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD><FONT size="2">(5)&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">Includes 281,001 shares issuable upon exercise of
    options that are exercisable within 60&nbsp;days.
    </FONT></TD>
</TR>

<TR>
    <TD>&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD><FONT size="2">(6)&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">Includes 218,000 shares issuable upon exercise of
    options that are exercisable within 60&nbsp;days. Does not
    include 138,750 shares issuable upon exercise of options not
    exercisable with 60&nbsp;days.
    </FONT></TD>
</TR>

<TR>
    <TD>&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD><FONT size="2">(7)&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">Includes 75,000 shares issuable upon exercise of
    options that are exercisable within 60&nbsp;days.
    </FONT></TD>
</TR>

<TR>
    <TD>&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD><FONT size="2">(8)&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">Includes 165,000 shares issuable upon exercise of
    options and warrants that are exercisable within 60&nbsp;days.
    </FONT></TD>
</TR>

<TR>
    <TD>&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD><FONT size="2">(9)&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">Includes 45,000 shares issuable upon exercise of
    options which are exercisable within 60&nbsp;days.
    </FONT></TD>
</TR>

</TABLE>
<P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="5%"></TD>
    <TD width="95%"></TD>
</TR>

<TR valign="top">
    <TD><FONT size="2">(10)&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">Includes 163,001 shares issuable upon exercise of
    options and warrants that are exercisable within 60&nbsp;days.
    </FONT></TD>
</TR>

<TR>
    <TD>&nbsp;</TD>
</TR>

<TR valign="top">
    <TD><FONT size="2">(11)&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">Includes 400,123 shares issuable upon exercise of
    options and warrants which are exercisable within 60&nbsp;days
    and 21,819 shares held by a limited partnership of which
    Mr.&nbsp;Starke is the general partner. Does not include 6,250
    shares issuable upon exercise of options not exercisable within
    60 days. Does not include 39,474 shares owned by various family
    members of Mr.&nbsp;Starke, as to which Mr.&nbsp;Starke
    disclaims beneficial ownership.
    </FONT></TD>
</TR>

<TR>
    <TD>&nbsp;</TD>
</TR>

<TR valign="top">
    <TD><FONT size="2">(12)&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">Includes 35,250 shares issuable upon exercise of
    options that are exercisable within 60&nbsp;days. Does not
    include 25,450 shares issuable upon exercise of options not
    exercisable within 60&nbsp;days.
    </FONT></TD>
</TR>

<TR>
    <TD>&nbsp;</TD>
</TR>

<TR valign="top">
    <TD><FONT size="2">(13)&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">Includes 197,500 shares issuable upon exercise of
    options that are exercisable within 60&nbsp;days. Does not
    include 182,500 shares issuable upon exercise of options not
    exercisable within 60&nbsp;days.
    </FONT></TD>
</TR>

<TR>
    <TD>&nbsp;</TD>
</TR>

<TR valign="top">
    <TD><FONT size="2">(14)&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">Includes 3,704,445 shares issuable upon exercise
    of options and warrants that are exercisable within
    60&nbsp;days. Does not include 590,450 shares issuable upon
    exercise of options not exercisable within 60&nbsp;days.
    </FONT></TD>
</TR>

<TR>
    <TD>&nbsp;</TD>
</TR>

<TR valign="top">
    <TD><FONT size="2">(15)&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">Includes 3,350,000 shares of the Company&#146;s
    Series&nbsp;A convertible preferred stock convertible into
    16,750,000 shares of common stock and 7,000,000 shares issuable
    upon the exercise of a warrant exercisable within the next
    60&nbsp;days.
    </FONT></TD>
</TR>

</TABLE>

<P align="center"><FONT size="2">3
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<!-- link1 "PROPOSAL 1" -->

<P align="center">
<B><FONT size="2">PROPOSAL 1</FONT></B>

<!-- link1 "ELECTION OF DIRECTORS" -->

<P align="center">
<B><FONT size="2">ELECTION OF DIRECTORS</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The Company&#146;s Board of Directors is divided
into three classes, as nearly equal in number as reasonably
possible, with terms currently expiring at the Annual Meeting,
the annual meeting of stockholders to be held in 2004 and the
annual meeting of stockholders to be held in 2005. As of the
date of the Annual Meeting, the size of the Board will be
reduced from seven directors to six directors. At the Annual
Meeting, two directors will be elected by the stockholders to
serve a three-year term. Management recommends that the persons
named below be elected as directors of the Company, and it is
intended that the accompanying proxy will be voted for the
election as directors of the two persons named below, unless the
proxy contains contrary instructions. The Company has no reason
to believe that either of the nominees will not be a candidate
or will be unable to serve. However, if either of the nominees
should become unable or unwilling to serve as a director, the
persons named in the proxy will vote (unless authority has been
withdrawn) for the election of such person or persons as shall
be designated by the Board of Directors.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">One of the two nominees currently serves as a
director of the Company; the second nominee does not currently
serve on the Board. Both nominees have consented to being named
in this Proxy Statement and to serve if elected.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The following sets forth the names and ages as of
April&nbsp;23, 2003 of the two nominees for election to the
Board of Directors, as well as the directors whose terms will
continue, their respective positions and offices with the
Company, the period during which each has served as a director
of the Company and their principal occupations or employment
during the past five years.
</FONT>

<CENTER>
<TABLE width="100%" align="center" cellspacing="0" cellpadding="0" border="0">

<TR>
    <TD width="38%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="1%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="1%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="36%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="7%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="1%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="6%"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
    <TD align="center" nowrap><B><FONT size="2">Name</FONT></B></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">Age</FONT></B></TD>
    <TD></TD>
    <TD align="center" nowrap><B><FONT size="2">Position</FONT></B></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">Director Since</FONT></B></TD>
</TR>

<TR>
    <TD align="center" nowrap><HR size="1" noshade></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><HR size="1" noshade></TD>
    <TD></TD>
    <TD align="center" nowrap><HR size="1" noshade></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><HR size="1" noshade></TD>
</TR>

<TR valign="bottom" bgcolor="#EEEEEE">
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">Michael Tarnow
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">58</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top">
    <FONT size="2">Chairman of the Board of Directors
    </FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">2003</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">Ronald Cape, Ph.D.
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">70</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top">
    <FONT size="2">Nominee
    </FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">&#151;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom" bgcolor="#EEEEEE">
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">Jerry Finkelstein(1)(2)(5)
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">87</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top">
    <FONT size="2">Director
    </FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">1998</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">Mark C. M. Randall(1)(4)
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">40</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top">
    <FONT size="2">Director
    </FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">1996</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom" bgcolor="#EEEEEE">
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">Donald S. Brooks
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">67</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top">
    <FONT size="2">Director
    </FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">1996</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">Peter S. Knight(2)(3)
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">52</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top">
    <FONT size="2">Director
    </FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">2000</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom" bgcolor="#EEEEEE">
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">Jennie C. Hunter-Cevera
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">55</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top">
    <FONT size="2">Director
    </FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">2001</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

</TABLE>
</CENTER>

<DIV align="left">
<HR size="1" width="18%" align="left" noshade>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="96%"></TD>
</TR>

<TR valign="top">
    <TD><FONT size="2">(1)&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">Member of Audit Committee
    </FONT></TD>
</TR>

<TR>
    <TD>&nbsp;</TD>
</TR>

<TR valign="top">
    <TD><FONT size="2">(2)&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">Member of Compensation Committee
    </FONT></TD>
</TR>

<TR>
    <TD>&nbsp;</TD>
</TR>

<TR valign="top">
    <TD><FONT size="2">(3)&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">Chairman of Audit Committee
    </FONT></TD>
</TR>

<TR>
    <TD>&nbsp;</TD>
</TR>

<TR valign="top">
    <TD><FONT size="2">(4)&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">Chairman of Compensation Committee
    </FONT></TD>
</TR>

<TR>
    <TD>&nbsp;</TD>
</TR>

<TR valign="top">
    <TD><FONT size="2">(5)&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">Retiring as of the date of the Annual Meeting.
    </FONT></TD>
</TR>

</TABLE>

<P align="left">
<B><FONT size="2">Nominees for Terms Expiring 2006</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<B><FONT size="2">Michael Tarnow </FONT></B><FONT size="2">was
appointed chairman of our Board in February 2003. Since 1995,
Mr.&nbsp;Tarnow has been an advisor to and member of the boards
of directors of several healthcare-related organizations in the
U.S., Canada and Europe. From 1995-2000, he was President and
CEO of Boston-based Creative BioMolecules, Inc. Prior to 1995,
he spent 22&nbsp;years at Merck &#38; Co., Inc., where he served
in a wide variety of positions including heading corporate
development, President and CEO of Merck Frosst Canada and
Executive Vice President of Merck-Medco. Mr.&nbsp;Tarnow
received his J.D. from the University of Illinois and his
bachelor&#146;s degree from Wayne State University.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<B><FONT size="2">Ronald Cape, Ph.D.
</FONT></B><FONT size="2">was the co-founder of Cetus
Corporation, a genetic engineering company, where he was
Chairman of the Board of Directors for 20&nbsp;years until the
company merged with Chiron Corporation in 1991. He was also a
founding member of the Industrial Biotechnology Association (now
the Biotechnology Industry Organization &#150; BIO) and served
as its President for three years. Since 199l Dr. Cape has been
an investor in the field of biotechnology and a board member of
many companies. He was the founding Chairman of Darwin Molecular
Corporation, which was later sold to Chiroscience plc., and is
Chairman and a Director
</FONT>

<P align="center"><FONT size="2">4
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV align="left">
<FONT size="2">of Caprion, Inc., Ellipsis Biotherapeutics
Corporation, and Neugenesis Corporation. He is also a Director
of Sunol Molecular Corporation.
</FONT>
</DIV>

<P align="left">
<B><FONT size="2">Continuing Directors for Terms Expiring
2004</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<B><FONT size="2">Donald S. Brooks </FONT></B><FONT size="2">has
been one of EntreMed&#146;s directors since April 1996 and was
Vice President, Legal Affairs from 1998 until August 2001.
Between 1993 and 1998, Mr.&nbsp;Brooks was a practicing attorney
with the law firm of Carella Byrne Bain Gilfillan Cecchi Stewart
and Olstein, Roseland, New Jersey, has represented the Company
on certain matters. Mr.&nbsp;Brooks continues to be of counsel
to the firm. Prior thereto, Mr.&nbsp;Brooks was employed by
Merck and Co., Inc. for 27&nbsp;years, most recently, from 1986
to 1993, as Senior Counsel. From 1980 to 1985, Mr.&nbsp;Brooks
served as a U.S. employer delegate to the Chemical Industries
Committee, International Labor Organization in Geneva,
Switzerland.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<B><FONT size="2">Peter S. Knight </FONT></B><FONT size="2">has
been a Director of the Company since June 2000 and is a Managing
Director of MetWest Financial, a Los Angeles based financial
services company. Mr.&nbsp;Knight was a principal in Sage
Venture Partners, a telecommunications investment firm and had
been a partner in the law firm of Wunder, Knight, Forscey &#38;
DeVierno from 1991 to 1999. In 1996, at the request of President
Clinton, Mr.&nbsp;Knight took a leave of absence from his firm
to serve as the National Campaign Manager for Clinton/ Gore
&#146;96. Prior to his partnership with the firm,
Mr.&nbsp;Knight was the General Counsel and Secretary of the
Medicis Pharmaceutical Corporation. In addition to the EntreMed
Board of Directors, Mr. Knight serves on the Board of Directors
of Whitman Education Group, providers of postsecondary
education, and Medicis Pharmaceutical Corporation, a
pharmaceutical company specializing in dermatology.
Mr.&nbsp;Knight also serves on the board of the Schroeder Family
of Mutual Funds. He serves on the Board of Directors for the
former Vice President&#146;s Residence Foundation, and the Board
of Directors of the Center for National Policy. He holds a Juris
Doctor degree from the Georgetown University Law Center and a
Bachelor of Arts degree from Cornell University.
</FONT>

<P align="left">
<B><FONT size="2">Continuing Directors for Terms Expiring
2005</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<B><FONT size="2">Mark C. M. Randall
</FONT></B><FONT size="2">has been a director of the Company
since April 1996. He has been CEO of Commander Asset Management
Ltd since May 2002. Prior to this appointment he was associated
with Sarasin International Securities Limited, London, England,
a wholly owned subsidiary of Bank Sarasin and Cie, a private
bank based in Switzerland, where he was a Director since 1994
and Managing Director since 1999. Mr.&nbsp;Randall also serves
as Chairman of Acorn Alternative Strategies (Overseas) Ltd., an
investment fund company.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<B><FONT size="2">Jennie C. Hunter-Cevera
</FONT></B><FONT size="2">has been a director of the Company
since June 2001. Dr.&nbsp;Hunter-Cevera is the President of the
University of Maryland Biotechnology Institute. Prior to joining
the University of Maryland in October of 1999,
Dr.&nbsp;Hunter-Cevera had been the head of the Center for
Environmental Biotechnology at Lawrence Berkeley National
Laboratory between November 1994 and September 1999.
Dr.&nbsp;Hunter-Cevera is Past-President of SIM and USFCC and is
an active member of ASM and ACS. She served as Senior Editor for
JIM for 10 years and has served as a reviewer for proposals in
metabolic biochemistry and bioremediation for NSF and DOE. She
was a member of the Secretary of Agriculture Glickman&#146;s
Genetic Resources Advisory Board, President Clinton&#146;s
Council on Biotechnology for the State Department, USA
representative to the OECD on Biological Resource Centers and
serves on the Advisory Board for the Leadership Alliance for
Biodiversity. She has given over 40 invited lectures, seven
keynote lectures, and is the author of several papers and holder
of two patents. Dr.&nbsp;Hunter-Cevera was elected to the
American Academy of Microbiology in 1995, the recipient of the
1996 SIM Charles Porter Award, elected as a SIM Fellow in 1997
and the 1999 Nath Lecturer at West Virginia University. She is
member of the State Department&#146;s Council on Biotechnology.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<B><FONT size="2">The Board of Directors recommends a vote FOR
the election of the nominated directors, and signed proxies that
are returned will be so voted unless otherwise instructed on the
proxy card.</FONT></B>

<P align="center"><FONT size="2">5
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<P align="left">
<B><FONT size="2">Board and Committee Meetings</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The Board of Directors of the Company held 10
meetings during the fiscal year ended December&nbsp;31, 2002
(&#147;fiscal 2002&#148;). Each of the directors, except for
Dr.&nbsp;Jennie Hunter-Cevera, attended at least 75% of the
meetings of the Board and the standing committees thereof on
which such director served that were held during fiscal 2002.
Dr.&nbsp;Hunter-Cevera was required to recuse herself from the
EntreMed Board of Directors for a two-month period while she
served on Maryland Governor-Elect Erlich&#146;s Executive
Council for Transition. Dr. Hunter-Cervera resumed her Board
role in February 2003.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The Board of Directors has two standing
committees. These are the Audit Committee and the Compensation
Committee.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The Audit Committee reviews, with the
Company&#146;s independent auditors, the scope and timing of
their audit services and any other services they are asked to
perform, their report on the Company&#146;s financial statements
following completion of their audit and the Company&#146;s
policies and procedures with respect to internal accounting and
financial controls. In addition, the Audit Committee makes
annual recommendations to the Board of Directors for the
appointment of independent public auditors for the ensuing year.
The Board of Directors has adopted a written charter for the
Audit Committee. All members of the Audit Committee are
independent as defined by Rule&nbsp;4200(a)(14) of the National
Association of Securities&#146; Dealers listing standards.
During 2002, the Audit Committee consisted of three directors,
Messrs.&nbsp;Finkelstein, Knight, and Randall.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The Compensation Committee reviews and recommends
to the Board of Directors the compensation and benefits of all
officers of the Company, reviews general policy matters relating
to compensation and benefits of employees of the Company and
administers the Company&#146;s stock option plans. During 2002,
the Compensation Committee consisted of three directors,
Messrs.&nbsp;Finkelstein, Knight, and Randall.
</FONT>

<P align="left">
<B><FONT size="2">Compensation of Directors</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Members of the Board of Directors did not receive
cash compensation for services during 2002. During 2002 each
director of the Company received automatic grants of
non-qualified stock options as follows: upon joining the Board
of Directors, each new director was granted an option to
purchase 15,000 shares of Common Stock; for services of Vice
Chairman of the Board, the Vice Chairman was granted an option
to purchase 15,000 shares in addition to options received in his
capacity as a director; each director whose term in office
continued or who was re-elected to the Board was granted a
vested stock option covering 20,000 shares on the date of the
annual meeting of stockholders. All directors continue to be
reimbursed for expenses actually incurred in connection with
attending meetings. In addition in February 2002, each member of
the Board of Directors received a vested supplemental option
grant to purchase 10,000 shares of Common Stock.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The Board of Directors is currently evaluating
the Company&#146;s Director compensation programs. Changes, if
any, will be adopted effective the date of our annual meeting.
It is currently expected that each new director will be granted
an option, vesting over three years, to purchase 50,000 shares
of Common Stock upon joining the Board. Continuing directors
will receive a vested option to purchase 20,000 shares of Common
Stock as of the date of each annual meeting. The Board also is
considering an annual retainer fee of $25,000 that would be
payable solely in restricted stock or restricted stock units.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Pursuant to a Board Service Agreement between the
Company&#146;s Chairman, Michael Tarnow, and the Company dated
February&nbsp;5, 2003, Mr.&nbsp;Tarnow is paid $5,000 per month
for his services as Chairman. He also received an option to
purchase 250,000 shares of Common Stock, 25% of which were
exercisable immediately and 25% of which become exercisable each
year over the next three years. Mr.&nbsp;Tarnow is also
reimbursed for expenses in connection with his service as
Chairman, including travel to and from Board meetings, and
participates in all other Board compensation programs, including
the receipt of the annual option grants granted to all directors
of the Company. Mr.&nbsp;Tarnow is also Chairman of Ferghana
Partners, Inc. (&#147;Ferghana&#148;), a non-executive position.
Ferghana, though affiliates, began providing financial advisory
services to us in 2002 and continues to do so. Ferghana is paid
a monthly retainer. In addition, Ferghana may receive additional
success-based compensation.
</FONT>

<P align="center"><FONT size="2">6
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The Company&#146;s Vice-Chairman,
Mr.&nbsp;Wendell Starke also received $60,133.38 for services in
2002 and was eligible to participate in our 2001 Long-Term
Incentive Plan. Mr.&nbsp;Starke is not standing for re-election
at the Annual Meeting.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Following Mr.&nbsp;Brook&#146;s retirement as our
Vice President of Legal Affairs as of August 2001,
Mr.&nbsp;Brooks serves as our consultant. He received $174,000
for these services in 2002.
</FONT>

<P align="center"><FONT size="2">7
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<!-- link1 "PROPOSAL 2" -->

<P align="center">
<B><FONT size="2">PROPOSAL 2</FONT></B>

<P align="center">
<B><FONT size="2">APPROVAL OF ADDITIONAL SHARES FOR ISSUANCE
UNDER THE COMPANY&#146;S 2001 LONG-TERM INCENTIVE PLAN, AS
AMENDED</FONT></B>

<P align="left">
<B><FONT size="2">General</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The Board has approved an amendment to the 2001
Plan, subject to stockholder approval, to increase the aggregate
number of shares of Common Stock authorized for issuance under
the 2001 Plan from a total of 3,250,000 shares to 4,250,000
shares.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The Board adopted the amendment to increase the
number of shares of Common Stock authorized for issuance under
the 2001 Plan to ensure that the Company can continue to grant
stock-based awards to directors and employees of and consultants
to the Company at levels determined appropriate by the Board and
a committee or committees appointed by the Board to administer
the 2001 Plan. Management and the Board believe that the use of
stock-based compensation is important to the Company to recruit
and retain qualified persons.
</FONT>

<P align="left">
<B><FONT size="2">Description of The 2001 Plan</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The following summary of the material features of
the 2001 Plan, as proposed to be amended, is qualified in its
entirety by reference to the full text of the 2001 Plan, a copy
of which is available by writing the Company, Investor
Relations, EntreMed, Inc., 9640 Medical Center Drive, Rockville,
Maryland 20850. Unless otherwise specified, capitalized terms
used herein have the meanings assigned to them in the 2001 Plan.
</FONT>

<P align="left">
<B><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Eligibility</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The 2001 Plan authorizes the grant of stock
options (including incentive stock options and nonqualified
stock options), stock appreciation rights, restricted or
unrestricted stock awards, phantom stock, performance awards, or
any combination of the foregoing to all persons who are at the
time of the grant of an award employees (including persons who
may become employees), officers, directors, or consultants of
the Company, or of any Affiliate of the Company, as may be
selected from time to time. Only employees of the Company, or of
any Parent or Subsidiary of the Company, are eligible to receive
grants of incentive stock options. As of March&nbsp;31, 2003,
the number of employees, officers and directors of the Company
eligible to receive grants under the 2001 Plan was approximately
50 persons. The number of consultants to the Company eligible to
receive grants under the 2001 Plan is not determinable.
</FONT>

<P align="left">
<B><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Administration</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The 2001 Plan is administered by the Board of
Directors or by a committee or committees appointed by the Board
(all of which will hereinafter be referred to as the
&#147;Administrator&#148;). The Administrator has all the powers
vested in it by the terms of the 2001 Plan, including the
authority to determine eligibility, to grant awards, prescribe
Grant Agreements evidencing such awards, establish programs for
granting awards, whether a stock option shall be an incentive
stock option or a nonqualified stock option, any exceptions to
nontransferability, any Performance Goals applicable to awards,
the period during which Awards may be exercised, and the period
during which awards shall be subject to restrictions, and
otherwise administer the 2001 Plan. In making these
determinations, the Administrator may take into account the
nature of the services rendered or to be rendered by the award
recipients, their present and potential contributions to the
success of the Company and its Affiliates, and such other
factors as the Administrator in its discretion shall deem
relevant. The Administrator may delegate to the Chief Executive
Officer of the Company the power to administer the 2001 Plan and
to exercise the full authority of the Administrator with respect
to awards granted to specified Participants or groups of
Participants.
</FONT>

<P align="center"><FONT size="2">8
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<P align="left">
<B><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shares Available
For The Plan</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">If the stockholders approve the increase in the
aggregate number of shares of Common Stock authorized for
issuance under the 2001 Plan, a maximum of 4,250,000 shares will
be available for grants and awards, an increase of 1,000,000
shares.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">At April&nbsp;23, 2003, 518,490 shares of Common
Stock (excluding any shares that might in the future be returned
to the 2001 Plan as a result of cancellations or expiration of
options) remained available for future grant under the 2001 Plan.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">If an award expires or terminates unexercised or
is forfeited, or if any shares of Common Stock are surrendered
to the Company in connection with an award, the shares of Common
Stock subject to such award and the surrendered shares will
become available for further awards under the 2001 Plan. The
number of shares of Common Stock subject to the 2001 Plan (and
the number of shares and terms of any award) may be adjusted by
the Administrator in the event of any change in the outstanding
Common Stock by reason of any stock dividend, spin-off,
split-up, reverse stock split, recapitalization,
reclassification, merger, consolidation, liquidation, business
combination or exchange of Common Stock and the like.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">A maximum of 750,000 such shares of Common Stock
may be granted to an individual during any three consecutive
calendar years.
</FONT>

<P align="left">
<B><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock
Options</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The 2001 Plan authorizes the grant of incentive
stock options and nonqualified stock options. Incentive stock
options are stock options that satisfy the requirements of
Section&nbsp;422 of the Code. Nonqualified stock options are
stock options that do not satisfy the requirements of
Section&nbsp;422 of the Code. Options granted under the 2001
Plan would entitle the grantee, upon exercise, to purchase a
specified number of shares of Common Stock from the Company at a
specified exercise price per share. The period of time during
which an option may be exercised, as well as any vesting
schedule, is determined by the Administrator, except that no
option may be exercised more than 10&nbsp;years after the date
of grant. Additionally, the exercise price per share and manner
of payment for shares of Common Stock purchased pursuant to
options are determined by the Administrator and, in the case of
nonqualified stock options, options must have an exercise price
at least equal to the par value of the Common Stock.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Incentive stock options must comply with
Section&nbsp;422 of the Code. Incentive stock options, thus,
must have an exercise price at least equal to Fair Market Value
on the date of grant. Additionally, no incentive stock option
may be granted under the 2001 Plan to any person who, at the
time of the grant, owns (or is deemed to own) stock possessing
more than 10% of the total combined voting power of the Company
or any parent corporation or subsidiary corporation, as defined
in Sections&nbsp;424(e) and (f)&nbsp;of the Code, respectively,
of the Company, unless the option&#146;s exercise price is at
least 110% of the Fair Market Value of the stock subject to the
option on the date of grant, and the term of the option does not
exceed five years from the date of grant. For incentive stock
options granted under the 2001 Plan, the aggregate Fair Market
Value, determined at the time of the grant, of the shares of
Common Stock with respect to which such options are exercisable
for the first time by an optionee during any calendar year
(under all such plans of the Company and its affiliates) may not
exceed $100,000.
</FONT>

<P align="left">
<B><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other
Awards</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">In addition to stock options, the 2001 Plan
authorizes the grant of stock appreciation rights, stock awards,
phantom stock and performance awards. The Company has not issued
any such awards and does not currently expect to issue them
under the 2001 Plan.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Subject to the terms of a particular grant, the
exercise of a stock appreciation right under the 2001 Plan would
entitle the grantee to receive in cash, Common Stock, or a
combination thereof, as specified in the Grant Agreement, the
excess of the Fair Market Value of a specified number of shares
of Common Stock on the date of exercise over the base price per
Share specified in the Grant Agreement. The 2001 Plan also
authorizes the grant of restricted and unrestricted stock awards
on terms and conditions, which terms and
</FONT>

<P align="center"><FONT size="2">9
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV align="left">
<FONT size="2">conditions may condition the vesting or payment
of such awards on the achievement of one or more Performance
Goals (as described below) established by the Administrator.
</FONT>
</DIV>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">In addition, the 2001 Plan authorizes the grant
of phantom stock in the form of awards denominated in
stock-equivalent units on terms and conditions, which terms and
conditions may condition the vesting or payment of such awards
on the achievement of one or more Performance Goals (as
described below), established by the Administrator. An award of
phantom stock may be settled in cash, Common Stock, or a
combination thereof, as specified in the Grant Agreement.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Finally, the 2001 Plan authorizes the grant of
performance awards, which become payable upon attainment of one
or more Performance Goals established by the Administrator.
Performance awards may be paid in cash, Common Stock, or a
combination thereof, as specified in the Grant Agreement.
</FONT>

<P align="left">
<B><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Performance
Goals</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">In its discretion, the Administrator may
condition the grant, vesting or payment of awards under the Plan
on the attainment of Performance Goals. The term
&#147;Performance Goals&#148; means performance goals
established by the Administrator which may be based on one or
more business criteria selected by the Administrator that apply
to an individual or group of individuals, a business unit, or
the Company and/or one or more of its Affiliates either
separately or together, over such performance period as the
Administrator may designate, including, but not limited to,
business criteria based on operating income, earnings or
earnings growth, sales, return on assets, equity or investment,
regulatory compliance, satisfactory internal or external audits,
improvement of financial ratings, achievement of balance sheet
or income statement objectives, or any other objective goals
established by the Administrator, and may be absolute in their
terms or measured against or in relationship to other companies
comparably, similarly or otherwise situated.
</FONT>

<P align="left">
<B><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Transferability</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Except as otherwise determined by the
Administrator or provided in a Grant Agreement, awards granted
under the 2001 Plan are not transferable except by will or the
laws of descent and distribution or pursuant to a qualified
domestic relations order as defined in Code Section&nbsp;414(p).
Unless otherwise determined by the Administrator, awards may be
exercised only by the grantee or by permitted transferees during
the lifetime of the grantee or, in the event of legal
disability, by the grantee&#146;s guardian or legal
representative.
</FONT>

<P align="left">
<B><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amendment and
Termination</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The Board of Directors may amend, alter or
terminate the 2001 Plan, or any portion thereof, at any time. No
award may be granted under the 2001 Plan after the close of
business on May&nbsp;14, 2011. Subject to other applicable
provisions of the Plan, all awards made under the 2001 Plan
prior to the termination of the 2001 Plan will remain in effect
until those awards have been satisfied or terminated.
</FONT>

<P align="left">
<B><FONT size="2">Summary of Certain Federal Income Tax
Consequences</FONT></B>

<P align="left">
<B><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The following discussion briefly summarizes
certain federal income tax aspects of stock options, stock
appreciation rights, stock awards, phantom stock, and
performance awards granted under the 2001 Plan. The rules
governing the tax treatment of awards and the receipt of shares
of Common Stock and/or cash in connection with such awards are
quite technical, so the following description of tax
consequences is necessarily general in nature and does not
purport to be complete. Moreover, statutory provisions are
subject to change, as are their interpretations, and their
application may vary in individual circumstances. Finally, the
tax consequences under applicable state and local law may not be
the same as under the federal income tax laws.
</FONT>

<P align="left">
<B><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incentive Stock
Options</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">In general, a grantee will not recognize income
on the grant or exercise of an incentive stock option. However,
the difference between the exercise price and the Fair Market
Value of the stock on the exercise
</FONT>

<P align="center"><FONT size="2">10
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV align="left">
<FONT size="2">date is an adjustment item for purposes of the
alternative minimum tax. Further, if a grantee does not exercise
an incentive stock within certain specified periods after
termination of employment, the grantee will recognize ordinary
income on the exercise of an incentive stock option in the same
manner as on the exercise of a nonqualified stock option, as
described below. The general rule is that gain or loss from the
sale or exchange of shares of Common Stock acquired on the
exercise of an incentive stock option will be treated as capital
gain or loss. If certain holding period requirements are not
met, however, the grantee generally will recognize ordinary
income at the time of the disposition. Gain recognized on the
disposition in excess of the ordinary income resulting therefrom
will be capital gain, and any loss recognized will be capital
loss.
</FONT>
</DIV>

<P align="left">
<B><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nonqualified
Stock Options, Stock Appreciation Rights, Phantom Stock, and
Performance Awards</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">A grantee generally is not required to recognize
income on the grant of a nonqualified stock option, a stock
appreciation right, or on the award of phantom stock or a
performance award. Instead, ordinary income generally is
required to be recognized on the date the nonqualified stock
option or stock appreciation right is exercised, or in the case
of an award of phantom stock or a performance award on the date
of payment of such award in cash or shares of Common Stock. In
general, the amount of ordinary income required to be
recognized, (a)&nbsp;in the case of a nonqualified stock option,
is an amount equal to the excess, if any, of the Fair Market
Value of the shares of Common Stock on the exercise date over
the exercise price, (b)&nbsp;in the case of a stock appreciation
right, the amount of cash and the Fair Market Value of any
shares of Common Stock received on exercise, and (c)&nbsp;in the
case of an award of phantom stock or a performance award, the
amount of cash and the Fair Market Value of any shares of Common
Stock received. In all three instances, ordinary income also
includes the amount of any taxes withheld upon payment of the
award.
</FONT>

<P align="left">
<B><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Restricted
Stock</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Shares of restricted stock awarded under the 2001
Plan will be subject to a substantial risk of forfeiture for the
period of time specified in the award. Unless a grantee of
restricted shares of Common Stock makes an election under
Section&nbsp;83(b) of the Code as described below, the grantee
generally is not required to recognize ordinary income on the
award of restricted stock. Instead, on the date the substantial
risk of forfeiture lapses, the grantee will be required to
recognize ordinary income in an amount equal to the excess, if
any, of the Fair Market Value of the shares of Common Stock on
such date over the amount, if any, paid for such shares. If a
grantee makes a Section 83(b) election to recognize ordinary
income on the date the restricted shares of Common Stock are
awarded, the amount of ordinary income required to be recognized
is an amount equal to the excess, if any, of the Fair Market
Value of the shares on the date of award over the amount, if
any, paid for such shares. In such case, the grantee will not be
required to recognize additional ordinary income when the
substantial risk of forfeiture lapses.
</FONT>

<P align="left">
<B><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unrestricted
Stock</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">In general, a grantee is required to recognize
ordinary income on the date of issuance of such unrestricted
shares of Common Stock to the grantee equal to the excess, if
any, of the Fair Market Value of such shares on such date over
the amount, if any, paid for such shares.
</FONT>

<P align="left">
<B><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain or Loss On
Sale or Exchange of 2001 Plan Shares</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">In general, gain or loss from the sale or
exchange of shares of Common Stock granted or awarded under the
2001 Plan will be treated as capital gain or loss, provided that
the shares are held as capital assets at the time of the sale or
exchange. However, if certain holding period requirements are
not satisfied at the time of a sale or exchange of shares of
Common Stock acquired upon exercise of an incentive stock option
(a &#147;disqualifying disposition&#148;), a grantee generally
will be required to recognize ordinary income upon such
disposition.
</FONT>

<P align="center"><FONT size="2">11
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<P align="left">
<B><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deductibility By
Company</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The Company generally is not allowed a deduction
in connection with the grant or exercise of an incentive stock
option. However, if a grantee is required to recognize income as
a result of a disqualifying disposition, the Company will be
entitled to a deduction equal to the amount of ordinary income
so recognized. In general, in the case of a nonqualified stock
option (including an incentive stock option that is treated as a
nonqualified stock option, as described above), a stock
appreciation right, a stock award, phantom stock, or a
performance award, the Company generally will be allowed a
deduction in an amount equal to the amount of ordinary income
recognized by the grantee, provided that certain income tax
reporting requirements are satisfied.
</FONT>

<P align="left">
<B><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Parachute
Payments</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Where payments to certain persons that are
contingent on a change in control exceed limits specified in the
Code, the person generally is liable for a 20% excise tax on,
and the corporation or other entity making the payment generally
is not entitled to any deduction for, a specified portion of
such payments. If the Administrator, in its discretion, grants
awards, the exercise date or payment of which is accelerated by
a change in control of the Company, such acceleration of the
exercise date or payment would be relevant in determining
whether the excise tax and deduction disallowance rules would be
triggered.
</FONT>

<P align="left">
<B><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Performance-Based
Compensation</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Subject to certain exceptions,
Section&nbsp;162(m) of the Code disallows federal income tax
deductions for compensation paid by a publicly held corporation
to certain executives to the extent the amount paid to the
executive exceeds $1&nbsp;million for the taxable year. The 2001
Plan has been designed to allow the Administrator to make awards
under the 2001 Plan that qualify under an exception to the
deduction limit of Section&nbsp;162(m) for
&#147;performance-based compensation.&#148;
</FONT>

<P align="left">
<B><FONT size="2">Options under Employee Benefit Plans</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The following table discloses certain information
about the options issued and available for issuance under all
outstanding Company option plans, as of December&nbsp;31, 2002.
As such, it does not include, the proposed increase that is the
subject of this Proposal 2.
</FONT>

<CENTER>
<TABLE width="100%" align="center" cellspacing="0" cellpadding="0" border="0">

<TR>
    <TD width="25%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="10%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="1%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="10%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="12%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="1%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="12%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="10%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="1%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="9%"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
    <TD></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">(a)</FONT></B></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">(b)</FONT></B></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">(c)</FONT></B></TD>
</TR>

<TR>
    <TD></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><HR size="1" noshade></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><HR size="1" noshade></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><HR size="1" noshade></TD>
</TR>

<TR>
    <TD></TD>
    <TD></TD>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">Number of securities</FONT></B></TD>
</TR>

<TR>
    <TD></TD>
    <TD></TD>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">remaining available for</FONT></B></TD>
</TR>

<TR>
    <TD></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">Number of securities to be</FONT></B></TD>
    <TD></TD>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">future issuance under</FONT></B></TD>
</TR>

<TR>
    <TD></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">issued upon exercise of</FONT></B></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">Weighted-average exercise price</FONT></B></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">equity compensation plans</FONT></B></TD>
</TR>

<TR>
    <TD></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">outstanding options,</FONT></B></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">of outstanding options,</FONT></B></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">(excluding securities</FONT></B></TD>
</TR>

<TR>
    <TD align="center" nowrap><B><FONT size="2">Plan category</FONT></B></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">warrants and rights</FONT></B></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">warrants and rights</FONT></B></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">reflecting in column (a))</FONT></B></TD>
</TR>

<TR>
    <TD align="center" nowrap><HR size="1" noshade></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><HR size="1" noshade></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><HR size="1" noshade></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><HR size="1" noshade></TD>
</TR>

<TR valign="bottom" bgcolor="#EEEEEE">
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">Equity compensation plans approved by security
    holders
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">6,152,053</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">$</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">12.4717</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">885,019</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">Equity compensation plans not approved by
    security holders
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">94,129</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">$</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">8.027</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">0</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom" bgcolor="#EEEEEE">
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">Total
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">6,246,182</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">$</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">12.40</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top" nowrap><FONT size="2">885,019</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

</TABLE>
</CENTER>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Warrants issued under the plans not approved by
security holders represent compensation for consulting services
rendered by the holders.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<B><FONT size="2">The Board of Directors recommends a vote for
the approval of the amendment to the Company&#146;s 2001 plan,
and signed proxies that are returned will be so voted unless
otherwise instructed on the proxy card.</FONT></B>

<P align="center"><FONT size="2">12
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<!-- link1 "PROPOSAL 3" -->

<P align="center">
<B><FONT size="2">PROPOSAL 3</FONT></B>

<!-- link1 "APPROVAL AND RATIFICATION OF THE APPOINTMENT OF INDEPENDENT AUDITORS" -->

<P align="center">
<B><FONT size="2">APPROVAL AND RATIFICATION</FONT></B>

<DIV align="center">
<B><FONT size="2">OF THE APPOINTMENT OF INDEPENDENT
AUDITORS</FONT></B>
</DIV>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The Board of Directors recommends a vote for the
approval and ratification of the appointment of Ernst &#38;
Young LLP, Certified Public Accountants, as the Company&#146;s
independent auditors for the fiscal year ending
December&nbsp;31, 2003 (&#147;fiscal 2003&#148;). Ernst &#38;
Young LLP have been the Company&#146;s auditors for the past
fiscal year and has no direct or indirect financial interest in
the Company. A representative of Ernst &#38; Young LLP is
expected to be present at the Annual Meeting with the
opportunity to make a statement if he or she desires to do so,
and will be available to respond to appropriate questions.
</FONT>

<P align="left">
<B><FONT size="2">Audit Fees</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The Company incurred from Ernst &#38; Young audit
fees of $172,268 in fiscal 2002 and $120,344 in fiscal 2001 for
audit fees, covering professional services rendered for
(1)&nbsp;the audit of the Company&#146;s annual financial
statements and (2)&nbsp;the reviews of the financial statements
included in the Company&#146;s quarterly reports on
Form&nbsp;10-Q for the first three quarters of 2002 and 2001.
</FONT>

<P align="left">
<B><FONT size="2">Audit-Related Fees</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The Company incurred from Ernst &#38; Young
audit-related fees of $62,823 in fiscal 2002 and $57,247 in
fiscal 2001, for services that are traditionally performed by
the independent accountants, such as employee benefit plan
audits, due diligence related to mergers and acquisitions,
accounting consultations and audits in connection with
acquisitions, internal control reviews, attest services not
required by statue or regulation and consultation concerning
financial accounting and reporting standards.
</FONT>

<P align="left">
<B><FONT size="2">Tax Fees</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The Company incurred from Ernst &#38; Young tax
fees of $12,220 in fiscal 2002 and $55,875 in fiscal 2001, for
tax services include a review of the company&#146;s tax returns
and reserves, and all services provided by the auditor&#146;s
tax division not related to the audit, such tax compliance
(preparation of tax returns, claims for refunds, tax
payment-planning services), tax planning and tax advice
(assistance with tax audits and appeals, tax advice related to
mergers and acquisitions or employee benefit plans, requests for
rulings or technical advice from taxing authorities).
</FONT>

<P align="left">
<B><FONT size="2">All Other Fees</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The Company did not incur fees from Ernst &#38;
Young for any other services in fiscal 2002 or fiscal 2001.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The Audit Committee has considered the
compatibility of non-audit services with the auditor&#146;s
independence.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<B><FONT size="2">The Board of Directors recommends a vote FOR
the approval and ratification of the appointment of Ernst &#38;
Young LLP as the Company&#146;s auditors for fiscal
2003.</FONT></B>

<P align="center"><FONT size="2">13
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<!-- link1 "REPORT OF THE AUDIT COMMITTEE" -->

<P align="center">
<B><FONT size="2"> REPORT OF THE AUDIT COMMITTEE</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The Board of Directors of the Company has
appointed an Audit Committee composed of 3 directors, each of
whom is independent under the National Association of Securities
Dealers&#146; listing standards, as applicable and as may be
modified or supplemented.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The Board of Directors has adopted a written
charter for the Audit Committee. The Audit Committee&#146;s job
is one of oversight as set forth in its Charter. It is not the
duty of the Audit Committee to prepare the Company&#146;s
financial statements, to plan or conduct audits, or to determine
that the Company&#146;s financial statements are complete and
accurate and are in accordance with generally accepted
accounting principles. The Company&#146;s management is
responsible for preparing the Company&#146;s financial
statements and for maintaining internal controls. The
independent auditors are responsible for auditing the financial
statements and for expressing an opinion as to whether those
audited financial statements fairly present the financial
position, results of operations, and cash flows to the Company
in conformity with generally accepted accounting principles.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The Audit Committee has reviewed and discussed
the Company&#146;s audited consolidated financial statements
with management and with Ernst &#38; Young LLP, the
Company&#146;s independent auditors for 2002.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The Audit Committee has discussed with Ernst
&#38; Young LLP the matters required to be discussed by
Statement on Accounting Standards No.&nbsp;61.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The Audit Committee has received from Ernst &#38;
Young LLP the written statements required by Independence
Standards Board Standard No.&nbsp;1, Independence Discussions
with Audit Committees, and has discussed Ernst &#38;
Young&#146;s independence with Ernst &#38; Young, and has
considered the compatibility of nonaudit services with the
auditor&#146;s independence.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Based on the review and discussions referred to
above, the Audit Committee has recommended to the Board of
Directors that the audited consolidated financial statements be
included in the Company&#146;s Annual Report on Form&nbsp;10-K
for the year ended December&nbsp;31, 2002 for filing with the
Securities and Exchange Commission (the &#147;SEC&#148;).
</FONT>

<P align="left">
<FONT size="2">By the Audit Committee:
</FONT>

<P align="left">
<FONT size="2">Peter S. Knight, Chairman
</FONT>

<DIV align="left">
<FONT size="2">Mark C. M. Randall
</FONT>
</DIV>

<DIV align="left">
<FONT size="2">Jerry Finkelstein
</FONT>
</DIV>

<P align="center"><FONT size="2">14
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<!-- link1 "EXECUTIVE COMPENSATION AND OTHER MATTERS" -->

<P align="center">
<B><FONT size="2"> EXECUTIVE COMPENSATION AND OTHER
MATTERS</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The following summary compensation table sets
forth the aggregate compensation paid or accrued by us to the
Chief Executive Officer and to executive officers whose annual
compensation exceeded $100,000 for fiscal 2002 (collectively,
the &#147;named executive officers&#148;) for services during
the fiscal years ended December 31, 2002, 2001 and 2000.
</FONT>

<!-- link1 "Summary Compensation Table" -->

<P align="center">
<B><FONT size="2">Summary Compensation Table</FONT></B>

<CENTER>
<TABLE width="100%" align="center" cellspacing="0" cellpadding="0" border="0">

<TR>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="36%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="2%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="1%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="1%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="4%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="1%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="4%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="4%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="1%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="5%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="1%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="5%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="5%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="1%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="5%"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">Long Term</FONT></B></TD>
    <TD></TD>
    <TD colspan="3"></TD>
</TR>

<TR>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">Compensation</FONT></B></TD>
    <TD></TD>
    <TD colspan="3"></TD>
</TR>

<TR>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">Awards</FONT></B></TD>
    <TD></TD>
    <TD colspan="3"></TD>
</TR>

<TR>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><HR size="1" noshade></TD>
    <TD></TD>
    <TD colspan="3"></TD>
</TR>

<TR>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">Securities</FONT></B></TD>
    <TD></TD>
    <TD colspan="3"></TD>
</TR>

<TR>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">Underlying</FONT></B></TD>
    <TD></TD>
    <TD colspan="3"></TD>
</TR>

<TR>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">Annual</FONT></B></TD>
    <TD></TD>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">Options/SARS</FONT></B></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">All Other</FONT></B></TD>
</TR>

<TR>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">Name and Principal Position</FONT></B></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">Year</FONT></B></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">Salary($)</FONT></B></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">Bonus($)</FONT></B></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">(#)</FONT></B></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">Compensation</FONT></B></TD>
</TR>

<TR>
    <TD colspan="3" align="center" nowrap><HR size="1" noshade></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><HR size="1" noshade></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><HR size="1" noshade></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><HR size="1" noshade></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><HR size="1" noshade></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><HR size="1" noshade></TD>
</TR>

<TR bgcolor="#EEEEEE">
    <TD colspan="3" align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">John W. Holaday, Ph.D.&nbsp;</FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">2002</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">398,825</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">&#151;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">280,000</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">22,343</FONT></TD>
    <TD align="left" valign="bottom" nowrap><FONT size="2">(2)</FONT></TD>
</TR>

<TR bgcolor="#EEEEEE">
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD colspan="2" align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">Chairman and Chief Executive Officer
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">2001</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">395,000</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">&#151;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">250,000</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">22,432</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR bgcolor="#EEEEEE">
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD colspan="2" align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">(Chairman until January&nbsp;31, 2003 and
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">2000</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">380,000</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">150,000</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">150,000</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">21,298</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR bgcolor="#EEEEEE">
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">CEO until November&nbsp;5, 2002)
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR bgcolor="#EEEEEE">
    <TD colspan="23"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
    <TD colspan="3" align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">Neil J. Campbell
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">2002</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">251,750</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">(1</FONT></TD>
    <TD align="left" valign="bottom" nowrap><FONT size="2">)</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">175,000</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">9,792</FONT></TD>
    <TD align="left" valign="bottom" nowrap><FONT size="2">(3)</FONT></TD>
</TR>

<TR>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD colspan="2" align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">President and Chief Operating Officer
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">2001</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">159,375</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">&#151;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">205,000</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">5,764</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
    <TD colspan="23"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR bgcolor="#EEEEEE">
    <TD colspan="3" align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">Dane R. Saglio
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">2002</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">122,812</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">(1</FONT></TD>
    <TD align="left" valign="bottom" nowrap><FONT size="2">)</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">35,000</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">9,792</FONT></TD>
    <TD align="left" valign="bottom" nowrap><FONT size="2">(3)</FONT></TD>
</TR>

<TR bgcolor="#EEEEEE">
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD colspan="2" align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">Chief Financial Officer
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">2001</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">105,962</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">15,000</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">14,200</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">9,881</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR bgcolor="#EEEEEE">
    <TD colspan="3"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">2000</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">87,000</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">9,548</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">11,500</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">5,102</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR bgcolor="#EEEEEE">
    <TD colspan="23"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
    <TD colspan="3" align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">Edward Gubish
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">2002</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">257,227</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">&#151;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">40,000</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">80,458</FONT></TD>
    <TD align="left" valign="bottom" nowrap><FONT size="2">(4)</FONT></TD>
</TR>

<TR>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD colspan="2" align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">President and Chief Operating Officer
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">2001</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">295,000</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">&#151;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">222,000</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">9,881</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD colspan="2" align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">(until October&nbsp;16, 2002)
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">2000</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">250,000</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">125,000</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">115,000</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">8,747</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
    <TD colspan="23"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR bgcolor="#EEEEEE">
    <TD colspan="3" align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">James D. Johnson, Ph.D., J.D.&nbsp;</FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">2002</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">209,383</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">(1</FONT></TD>
    <TD align="left" valign="bottom" nowrap><FONT size="2">)</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">100,000</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">666</FONT></TD>
    <TD align="left" valign="bottom" nowrap><FONT size="2">(3)</FONT></TD>
</TR>

<TR bgcolor="#EEEEEE">
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD colspan="2" align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">Senior Vice President and General
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">2001</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">183,333</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">&#151;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">195,000</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">683</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR bgcolor="#EEEEEE">
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">Counsel
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

</TABLE>
</CENTER>

<DIV align="left">
<HR size="1" width="18%" align="left" noshade>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="96%"></TD>
</TR>

<TR valign="top">
    <TD><FONT size="2">(1)&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">Consideration of bonuses for 2002 has been
    deferred.
    </FONT></TD>
</TR>

<TR>
    <TD>&nbsp;</TD>
</TR>

<TR valign="top">
    <TD><FONT size="2">(2)&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">$12,551 of such amount represents the premiums
    paid by us with respect to a split-dollar life insurance policy
    on the life of Dr.&nbsp;Holaday. Premiums paid by us on such
    policy are treated as non-interest bearing advances to the
    insured for the policy. The initial proceeds of any death
    benefit are required to be used to repay the indebtedness, and
    the balance of the insurance proceeds are payable as designated
    by the insured. See &#147;Employment Contracts and Termination
    of Employment and Change-in-Control Arrangements&#148;. The
    remaining amount represents group health insurance premiums paid
    on behalf of such officer.
    </FONT></TD>
</TR>

<TR>
    <TD>&nbsp;</TD>
</TR>

<TR valign="top">
    <TD><FONT size="2">(3)&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">Consists of group health insurance premiums paid
    on behalf of such officer.
    </FONT></TD>
</TR>

<TR>
    <TD>&nbsp;</TD>
</TR>

<TR valign="top">
    <TD><FONT size="2">(4)&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">$70,666 of such amount represents severance
    payments pursuant to the terms of a separation agreement dated
    September&nbsp;18, 2002. The remaining amount represents health
    insurance premiums paid on behalf of such officer. The terms of
    this separation agreement expired October&nbsp;15, 2003.
    </FONT></TD>
</TR>

</TABLE>

<P align="center"><FONT size="2">15
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The following table sets forth certain
information with respect to individual grants of stock options
made during the fiscal year ended December&nbsp;31, 2002 to each
of the named executive officers.
</FONT>

<!-- link1 "Option/SAR Grants in Last Fiscal Year" -->

<P align="center">
<B><FONT size="2">Option/ SAR Grants in Last Fiscal
Year</FONT></B>

<CENTER>
<TABLE width="100%" align="center" cellspacing="0" cellpadding="0" border="0">

<TR>
    <TD width="34%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="4%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="1%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="4%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="4%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="1%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="4%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="1%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="4%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="1%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="4%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="1%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="1%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
    <TD></TD>
    <TD></TD>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="7"></TD>
</TR>

<TR>
    <TD></TD>
    <TD></TD>
    <TD colspan="11"></TD>
    <TD></TD>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="7" align="center" nowrap><B><FONT size="2">Potential Realizable</FONT></B></TD>
</TR>

<TR>
    <TD></TD>
    <TD></TD>
    <TD colspan="11" align="center" nowrap><B><FONT size="2">Individual Grants</FONT></B></TD>
    <TD></TD>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="7" align="center" nowrap><B><FONT size="2">Value at Assumed</FONT></B></TD>
</TR>

<TR>
    <TD></TD>
    <TD></TD>
    <TD colspan="11" align="center" nowrap><HR size="1" noshade></TD>
    <TD></TD>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="7" align="center" nowrap><B><FONT size="2">Annual</FONT></B></TD>
</TR>

<TR>
    <TD></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">Number of</FONT></B></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">% of Total</FONT></B></TD>
    <TD></TD>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="7" align="center" nowrap><B><FONT size="2">Rates of Stock Price</FONT></B></TD>
</TR>

<TR>
    <TD></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">Securities</FONT></B></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">Options/SARs</FONT></B></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">Exercise</FONT></B></TD>
    <TD></TD>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="7" align="center" nowrap><B><FONT size="2">Appreciation for</FONT></B></TD>
</TR>

<TR>
    <TD></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">Underlying</FONT></B></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">Granted to</FONT></B></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">or Base</FONT></B></TD>
    <TD></TD>
    <TD colspan="3"></TD>
    <TD></TD>
    <TD colspan="7" align="center" nowrap><B><FONT size="2">Option Term(1)</FONT></B></TD>
</TR>

<TR>
    <TD></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">Options/SARs</FONT></B></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">Employees in</FONT></B></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">Price</FONT></B></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">Expiration</FONT></B></TD>
    <TD></TD>
    <TD colspan="7" align="center" nowrap><HR size="1" noshade></TD>
</TR>

<TR>
    <TD align="center" nowrap><B><FONT size="2">Name</FONT></B></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">Granted(#)</FONT></B></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">Fiscal Year</FONT></B></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">($/sh)</FONT></B></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">Date</FONT></B></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">5%($)</FONT></B></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">10%($)</FONT></B></TD>
</TR>

<TR>
    <TD align="center" nowrap><HR size="1" noshade></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><HR size="1" noshade></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><HR size="1" noshade></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><HR size="1" noshade></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><HR size="1" noshade></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><HR size="1" noshade></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><HR size="1" noshade></TD>
</TR>

<TR bgcolor="#EEEEEE">
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">John W. Holaday, Ph.D.&nbsp;</FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">10,000</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">.10</FONT></TD>
    <TD align="left" valign="bottom" nowrap><FONT size="2">%</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">6.33</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">2/25/2012</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">39,809</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">100,884</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR bgcolor="#EEEEEE">
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">20,000</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">.20</FONT></TD>
    <TD align="left" valign="bottom" nowrap><FONT size="2">%</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">4.85</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">6/6/2012</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">61,003</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">154,593</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR bgcolor="#EEEEEE">
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">250,000</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">2.48</FONT></TD>
    <TD align="left" valign="bottom" nowrap><FONT size="2">%</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">1.09</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">9/25/2012</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">171,374</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">434,295</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">Gubish, Edward
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">40,000</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">.40</FONT></TD>
    <TD align="left" valign="bottom" nowrap><FONT size="2">%</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">1.09</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">9/25/2012</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">27,420</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">69,487</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR bgcolor="#EEEEEE">
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">Neil J. Campbell
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">175,000</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">1.74</FONT></TD>
    <TD align="left" valign="bottom" nowrap><FONT size="2">%</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">1.09</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">9/25/2012</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">119,962</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">304,006</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">Dane R. Saglio
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">5,000</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">.10</FONT></TD>
    <TD align="left" valign="bottom" nowrap><FONT size="2">%</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">7.50</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">4/17/2012</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">47,167</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">119,531</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">5,000</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">.10</FONT></TD>
    <TD align="left" valign="bottom" nowrap><FONT size="2">%</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">7.50</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">4/17/2012</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">47,167</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">119,531</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">25,000</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">.25</FONT></TD>
    <TD align="left" valign="bottom" nowrap><FONT size="2">%</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">1.09</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">9/25/2012</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">17,137</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">43,429</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR bgcolor="#EEEEEE">
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">James D. Johnson, Ph.D., J.D.&nbsp;</FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">100,000</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">.99</FONT></TD>
    <TD align="left" valign="bottom" nowrap><FONT size="2">%</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">1.09</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">9/25/2012</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">68,550</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">173,718</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

</TABLE>
</CENTER>

<DIV align="left">
<HR size="1" width="18%" align="left" noshade>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="96%"></TD>
</TR>

<TR valign="top">
    <TD><FONT size="2">(1)&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">Calculated by multiplying the exercise price by
    the annual appreciation rate shown (as prescribed by SEC rules
    and compounded for the term of the options), subtracting the
    exercise price per share and multiplying the gain per share by
    the number of shares covered by the options. These amounts are
    not intended to forecast possible future appreciation, if any,
    of the price of our shares. The actual value realized upon
    exercise of the options to purchase our shares will depend on
    the fair market value of our shares on the date of exercise.
    </FONT></TD>
</TR>

</TABLE>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The following table sets forth information
concerning all option holdings for the fiscal year ended
December&nbsp;31, 2002 for each of the named executive officers.
</FONT>

<!-- link1 "Aggregated Option/SAR Exercises in Last Fiscal Year and Fiscal Year End Option/SAR Values" -->

<P align="center">
<B><FONT size="2">Aggregated Option/ SAR Exercises in Last
Fiscal Year and</FONT></B>

<DIV align="center">
<B><FONT size="2">Fiscal Year End Option/ SAR Values</FONT></B>
</DIV>

<CENTER>
<TABLE width="100%" align="center" cellspacing="0" cellpadding="0" border="0">

<TR>
    <TD width="47%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="4%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="1%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="4%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="5%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="1%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="5%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="5%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="4%"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
    <TD></TD>
    <TD></TD>
    <TD colspan="7"></TD>
    <TD></TD>
    <TD colspan="7"></TD>
</TR>

<TR>
    <TD></TD>
    <TD></TD>
    <TD colspan="7" align="center" nowrap><B><FONT size="2">Number of Securities</FONT></B></TD>
    <TD></TD>
    <TD colspan="7" align="center" nowrap><B><FONT size="2">Value of Unexercised</FONT></B></TD>
</TR>

<TR>
    <TD></TD>
    <TD></TD>
    <TD colspan="7" align="center" nowrap><B><FONT size="2">Underlying Options/SARs</FONT></B></TD>
    <TD></TD>
    <TD colspan="7" align="center" nowrap><B><FONT size="2">In-the-Money Options/SARs</FONT></B></TD>
</TR>

<TR>
    <TD></TD>
    <TD></TD>
    <TD colspan="7" align="center" nowrap><B><FONT size="2">at Fiscal Year-End (#)</FONT></B></TD>
    <TD></TD>
    <TD colspan="7" align="center" nowrap><B><FONT size="2">at Fiscal Year-End($)(1)</FONT></B></TD>
</TR>

<TR>
    <TD></TD>
    <TD></TD>
    <TD colspan="7" align="center" nowrap><HR size="1" noshade></TD>
    <TD></TD>
    <TD colspan="7" align="center" nowrap><HR size="1" noshade></TD>
</TR>

<TR>
    <TD align="center" nowrap><B><FONT size="2">Name</FONT></B></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">Exercisable</FONT></B></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">Unexercisable</FONT></B></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">Exercisable</FONT></B></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><B><FONT size="2">Unexercisable</FONT></B></TD>
</TR>

<TR>
    <TD align="center" nowrap><HR size="1" noshade></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><HR size="1" noshade></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><HR size="1" noshade></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><HR size="1" noshade></TD>
    <TD></TD>
    <TD colspan="3" align="center" nowrap><HR size="1" noshade></TD>
</TR>

<TR valign="bottom" bgcolor="#EEEEEE">
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">John W. Holaday Ph.D. (2)
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">1,152,318</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">284,751</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">&#151;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">&#151;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">Edward G. Gubish
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">672,001</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">&#151;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">&#151;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">&#151;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom" bgcolor="#EEEEEE">
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">Neil J. Campbell
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">190,000</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">190,000</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">&#151;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">&#151;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR>
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">Dane R. Saglio
    </FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">29,625</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">31,075</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">&#151;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">&#151;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom" bgcolor="#EEEEEE">
    <TD align="left" valign="top">
    <DIV style="margin-left:10px; text-indent:-10px">
    <FONT size="2">James D. Johnson Ph.D., J.D.&nbsp;</FONT></DIV>
    </TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">205,500</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">151,250</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">&#151;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="bottom" nowrap><FONT size="2">&#151;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

</TABLE>
</CENTER>

<DIV align="left">
<HR size="1" width="18%" align="left" noshade>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="96%"></TD>
</TR>

<TR valign="top">
    <TD><FONT size="2">(1)&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">Calculated by multiplying the number of
    unexercised options outstanding at December&nbsp;31, 2002 by the
    difference between the fair market value of our shares at
    December&nbsp;31, 2002 ($0.86) and the option exercise price.
    </FONT></TD>
</TR>

<TR valign="top">
    <TD><FONT size="2">(2)&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">Holdings include warrants issued in lieu of stock
    options.
    </FONT></TD>
</TR>

</TABLE>

<P align="left">
<B><FONT size="2">Employment Contracts and Termination of
Employment and Change-In-Control Arrangements</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The employment of Dr.&nbsp;John Holaday, our
former Chairman and Chief Science Officer, was terminated
pursuant to a Transition Agreement entered into between the
Company and Dr.&nbsp;Holaday on January&nbsp;31, 2003. Pursuant
to the Transition Agreement, Dr.&nbsp;Holaday received a
lump-sum severance payment of $55,650 and a
</FONT>

<P align="center"><FONT size="2">16
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV align="left">
<FONT size="2">lump-sum payment of $50,513.44 for accrued but
unused paid time off. Dr. Holaday will also receive
twice-monthly payments of $20,405 for 12&nbsp;months. In
addition, we agreed to accelerate the vesting of certain stock
options held by Dr.&nbsp;Holaday. Dr.&nbsp;Holaday was also
granted a warrant to purchase up to 100,000 shares of the
Company&#146;s Common Stock at $1.04 per share; 10,000 of the
options become exercisable each month beginning February 2003
and expire if not exercised within that month. We will also pay
up to $10,000 for executive outplacement services for
Dr.&nbsp;Holaday. In addition, the Company will maintain and pay
the premiums for Dr.&nbsp;Holaday&#146;s medical insurance in
effect as of his termination date through January&nbsp;31, 2004.
Finally, the Company paid the annual premium for a life
insurance policy covering Dr.&nbsp;Holaday and his wife for the
annual period beginning February&nbsp;26, 2003.
</FONT>
</DIV>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Edward Gubish, our former President and Chief
Operating Officer, left the Company on October&nbsp;15, 2002.
Pursuant to a Confidential Separation Agreement and Mutual
Release between the Company and Dr.&nbsp;Gubish dated
September&nbsp;18, 2002, Dr.&nbsp;Gubish received as severance
12&nbsp;months of his salary or $339,199.92. He also received
stock options for 2001 and 2002 as disclosed in the summary
compensation table. In addition, we agreed to accelerate the
vesting of certain stock options held by Dr.&nbsp;Gubish.
Finally, we agreed to maintain Dr. Gubish&#146;s health
insurance through the Company and to pay the premiums for such
insurance for a period of 12&nbsp;months or, if earlier, until
he secured other employment.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">On April&nbsp;30, 2003, we entered into a new
employment agreement with Neil Campbell. This agreement
supercedes the Change of Control Agreement we had entered into
with Mr.&nbsp;Campbell on August&nbsp;1, 2002. Pursuant to the
agreement, Mr.&nbsp;Campbell will serve as President and Chief
Operating Officer of the Company, or such other executive
positions as determined by the Board of Directors, for an annual
base salary of $300,000 per year (retroactive to January&nbsp;1,
2003) with annual upward adjustments as determined by the Board
of Directors. Pursuant to the agreement, Mr.&nbsp;Campbell will
also receive a payment equal to six months of his base salary in
effect on December&nbsp;31, 2002. The agreement also provides
for the acceleration of vesting of stock options held by
Mr.&nbsp;Campbell. The effects of the acceleration are not
reflected in the Security Ownership Table on page&nbsp;2. The
agreement has a one-year term beginning January&nbsp;1, 2003
that can be renewed by mutual written agreement for successive
one-year periods. The agreement contains confidentiality and
non-competition provisions.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Each of our employees has entered into a
Proprietary Information and Invention Assignment Agreement
providing, among other things, that such employee will not
disclose any confidential information or trade secrets in any
unauthorized manner and that all inventions of such employee
relating to our current or anticipated business during the term
of employment become our property.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">In the event of certain transactions, including
those that may result in a change in control, as defined under
our Incentive Stock Option Plans, unvested installments of
options to purchase our shares may become immediately
exercisable.
</FONT>

<P align="left">
<B><FONT size="2">Section&nbsp;16(a) Beneficial Ownership
Reporting Compliance</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Section&nbsp;16(a) of the 1934 Securities and
Exchange Act (the &#147;1934 Act&#148;) requires the
Company&#146;s executive officers, directors and persons who
beneficially own more than 10% of a registered class of the
Company&#146;s equity securities to file with the SEC initial
reports of ownership and reports of changes in ownership of
Common Stock and other equity securities of the Company. Such
executive officers, directors, and greater than 10% beneficial
owners are required by SEC regulation to furnish the Company
with copies of all Section&nbsp;16(a) reports filed by such
reporting persons.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Based solely on our review of such forms
furnished to the Company and written representations from
certain reporting persons, we believe that all filing
requirements applicable to our executive officers, directors and
greater than 10% beneficial owners were complied with.
</FONT>

<P align="center"><FONT size="2">17
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<!-- link1 "BOARD COMPENSATION COMMITTEE REPORT ON EXECUTIVE COMPENSATION" -->

<P align="center">
<B><FONT size="2">BOARD COMPENSATION COMMITTEE REPORT ON
EXECUTIVE COMPENSATION</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<B><FONT size="2">The Compensation Committee is comprised of
three independent, non-employee directors. It is the
Committee&#146;s responsibility to:</FONT></B>
<P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD width="96%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD><FONT size="2">&#149;&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">Make recommendations and report to the board of
    directors concerning matters of executive compensation;
    </FONT></TD>
</TR>

<TR>
    <TD>&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD><FONT size="2">&#149;&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">Administer the Company&#146;s executive incentive
    plans;
    </FONT></TD>
</TR>

<TR>
    <TD>&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD><FONT size="2">&#149;&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">Review compensation plans, programs and policies;
    and
    </FONT></TD>
</TR>

<TR>
    <TD>&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD><FONT size="2">&#149;&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">Monitor the performance and compensation of
    executive officers.
    </FONT></TD>
</TR>

</TABLE>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The goal of the Company&#146;s executive
compensation policy is to ensure that an appropriate
relationship exists between executive compensation and the
creation of stockholder value, while at the same time
attracting, motivating and retaining senior management. The
Compensation Committee&#146;s informal executive compensation
philosophy (which applies generally to all Company management,
including its executive officers) considers a number of factors,
which may include:
</FONT>
<P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD width="96%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD><FONT size="2">&#149;&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">Providing levels of compensation competitive with
    companies at a comparable stage of development and in the
    Company&#146;s geographic area;
    </FONT></TD>
</TR>

<TR>
    <TD>&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD><FONT size="2">&#149;&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">Integrating management&#146;s compensation with
    the achievement of performance goals;
    </FONT></TD>
</TR>

<TR>
    <TD>&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD><FONT size="2">&#149;&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">Maintaining an appropriate balance between base
    salary and performance-based compensation, with a higher
    proportion of compensation being performance-based as salary
    grade increases; and
    </FONT></TD>
</TR>

<TR>
    <TD>&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD><FONT size="2">&#149;&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">Recognizing and providing incentive for
    individual initiative and achievement.
    </FONT></TD>
</TR>

</TABLE>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The compensation structure of the Company&#146;s
executive officers is based on competitive, market-based pay
practices and performance evaluations, and generally includes a
combination of base salary, discretionary bonuses and stock
options. In setting compensation levels, the Compensation
Committee considers data regarding compensation practices from a
group of biotechnology and pharmaceutical companies that are
believed to be generally comparable to the Company. The
companies comprising this group are not necessarily included
within the peer group index reflected in the performance graph
illustrated in this proxy.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Base salary is not targeted at any particular
level within the group of companies considered. Instead, total
salary is determined based on a subjective assessment of the
executive&#146;s performance and the Company&#146;s needs.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Cash bonuses are within the discretion of the
Compensation Committee and are based, in part, on achieving
certain business and financial objectives and the Compensation
Committee&#146;s subjective assessment of individual performance
during the year. The Compensation Committee has deferred
consideration of bonuses for fiscal 2002.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Consistent with its belief that equity ownership
by senior management is beneficial in aligning the interests of
senior management with those of the stockholders, the Company
provides potentially significant long-term incentive
opportunities to its senior management through discretionary
grants of stock options, thereby emphasizing the potential
creation of long-term stockholder value. The Compensation
Committee considers stock options effective long-term incentives
because an executive can profit only if the value of the Common
Stock increases. In making these grants, the Compensation
Committee considers its subjective assessment of the
Company&#146;s past financial performance and future prospects,
an executive officer&#146;s current level of ownership of the
Common Stock, the period during which an executive officer has
been in a key position with the Company, individual performance
and competitive practices within the comparative group of
companies.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Section&nbsp;162(m) of the Internal Revenue Code
generally denies a deduction to any publicly held corporation
for compensation paid to its chief executive officer and its
four other highest-paid executive officers to the extent that
any such individual&#146;s compensation exceeds $1&nbsp;million,
subject to certain exceptions.
</FONT>

<P align="center"><FONT size="2">18
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV align="left">
<FONT size="2">The Committee intends to take actions to minimize
the Company&#146;s exposure to nondeductible compensation
expense under Section&nbsp;162(m). While keeping this goal in
mind, the Committee also will try to maintain the flexibility
that the Committee believes to be an important element of the
Company&#146;s executive compensation program.
</FONT>
</DIV>

<P align="left">
<FONT size="2">By the Compensation Committee:
</FONT>

<P align="left">
<FONT size="2">Mark C. M. Randall, Chairman
</FONT>

<DIV align="left">
<FONT size="2">Peter S. Knight
</FONT>
</DIV>

<DIV align="left">
<FONT size="2">Jerry Finkelstein
</FONT>
</DIV>

<P align="center"><FONT size="2">19
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<!-- link1 "STOCK PRICE PERFORMANCE PRESENTATION" -->

<P align="center">
<B><FONT size="2">STOCK PRICE PERFORMANCE PRESENTATION</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The following chart compares the cumulative total
stockholder return on the Company&#146;s Common Stock with the
cumulative total stockholder return of the NASDAQ Stock Market
&#150; U. S. Index, and the NASDAQ Pharmaceuticals Index.
</FONT>

<P align="center">
<IMG src="w86899dfw8689901.gif" alt="LOGO">

<P align="left">
<HR size="1" width="18%" align="left" noshade>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="96%"></TD>
</TR>

<TR valign="top">
    <TD><FONT size="2">(1)&nbsp;</FONT></TD>
    <TD align="left">
    <FONT size="2">Assumes $100 invested on December&nbsp;31, 1997
    and assumes dividends are reinvested. Measurement points begin
    with the date of the assumed investment and include the last day
    of each of the subsequent 5&nbsp;years through and including
    December&nbsp;31, 2002. The material in this chart is not
    soliciting material, is not deemed filed with the SEC and is not
    incorporated by reference in any filing of the Company under the
    Securities Act of 1933, as amended, (the &#147;1933 Act&#148;)
    or the 1934 Act, whether made before or after the date of this
    proxy statement and irrespective of any general incorporation
    language in such filing.
    </FONT></TD>
</TR>

</TABLE>

<!-- link1 "CERTAIN TRANSACTIONS" -->

<P align="center">
<B><FONT size="2">CERTAIN TRANSACTIONS</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">James D. Johnson, our Senior Vice President, is a
partner at Kilpatrick, Stockton, which provides certain patent
prosecution and certain other legal services to us. We paid
approximately $3,774,709 to Kilpatrick, Stockton for these
services in 2002. The amount paid represents less than 5% of
Kilpatrick, Stockton&#146;s total revenues for 2002.
</FONT>

<!-- link1 "GENERAL" -->

<P align="center">
<B><FONT size="2">GENERAL</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The Management of the Company does not know of
any matters other than those stated in this Proxy Statement that
are to be presented for action at the Annual Meeting. If any
other matters should properly come before the Annual Meeting, it
is intended that proxies in the accompanying form will be voted
on any such other matters in accordance with the judgment of the
persons voting such proxies. Discretionary authority to vote on
such matters is conferred by such proxies upon the persons
voting them.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The Company will bear the cost of preparing,
printing, assembling, and mailing the proxy, Proxy Statement and
other material that may be sent to stockholders in connection
with this solicitation. It is contemplated that brokerage houses
will forward the proxy materials to beneficial owners at the
request of the
</FONT>

<P align="center"><FONT size="2">20
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV align="left">
<FONT size="2">Company. In addition to the solicitation of
proxies by use of the mails, officers and regular employees of
the Company may solicit proxies by telephone without additional
compensation. The Company does not expect to pay any
compensation for the solicitation of proxies.
</FONT>
</DIV>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The Company will provide without charge to each
person being solicited by the Proxy Statement, on the written
request of any such person, a copy of the Annual Report of the
company on Form&nbsp;10-K for the fiscal year ended December 31,
2002 (as filed with the SEC, including the financial statements
thereto). All such requests should be directed to Investor
Relations, EntreMed, Inc., 9640 Medical Center Drive, Rockville,
Maryland 20850.
</FONT>

<!-- link1 "STOCKHOLDER PROPOSALS" -->

<P align="center">
<B><FONT size="2">STOCKHOLDER PROPOSALS</FONT></B>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">The annual meeting of stockholders for the fiscal
year ending December&nbsp;31, 2003 is expected to be held in
June 2004 (the &#147;Next Annual Meeting&#148;). All proposals
intended to be presented at the Next Annual Meeting must be
received at the Company&#146;s executive offices,<B> </B>which
are located at 9640 Medical Center Drive, Rockville, Maryland
20850, Attention: Corporate Secretary, no later than
January&nbsp;24, 2004, to receive consideration for inclusion in
the Proxy Statement and form of proxy related to that meeting.
</FONT>

<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT size="2">Pursuant to the proxy rules under the 1934 Act,
the Company&#146;s stockholders are notified that the deadline
for providing the Company with timely notice of any stockholder
proposal to be submitted outside of the Rule&nbsp;14a-8 process
for consideration at the Next Annual Meeting will be
April&nbsp;8, 2004. As to all such matters which the Company
does not have notice on or prior to that date, discretionary
authority to vote on such proposal shall be granted to the
persons designated in the Company&#146;s proxy related to the
Next Annual Meeting.
</FONT>
<P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="44%"></TD>
    <TD width="56%"></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    <FONT size="2">By Order of the Board of Directors,
    </FONT></TD>
</TR>

<TR>
    <TD>&nbsp;</TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    <FONT size="2">Michael Tarnow
    </FONT></TD>
</TR>

<TR valign="top">
    <TD>&nbsp;</TD>
    <TD align="left">
    <I><FONT size="2">Chairman of the Board</FONT></I></TD>
</TR>

</TABLE>

<P align="left">
<FONT size="2">May&nbsp;23, 2003
</FONT>

<P align="center"><FONT size="2">21
</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<P align="right"><FONT size="2">EXHIBIT A
</FONT>

<P align="center"><FONT size="2">ENTREMED, INC.
</FONT>
<P align="center"><FONT size="2">2001 LONG-TERM INCENTIVE PLAN, AS AMENDED
</FONT>
<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR valign="top">
        <TD width="1%" align="left" nowrap><FONT size="2">1.</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="96%"><FONT size="2">PURPOSE AND TYPES OF AWARDS</FONT></TD>
</TR>
</TABLE>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The purpose of the 2001 Long-Term Incentive Plan (&#147;Plan&#148;) is to promote
the long-term growth and profitability of the Corporation by: (i)&nbsp;providing key
people with incentives to improve stockholder value and to contribute to the
growth and financial success of the Corporation and (ii)&nbsp;enabling the
Corporation to attract, retain and reward the best-available persons.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Plan permits the granting of stock options (including incentive
stock options qualifying under Code section 422 and nonqualified stock options),
stock appreciation rights, restricted or unrestricted stock awards, phantom
stock, performance awards, or any combination of the foregoing.
</FONT>
<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR valign="top">
        <TD width="1%" align="left" nowrap><FONT size="2">2.</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="96%"><FONT size="2">DEFINITIONS</FONT></TD>
</TR>
</TABLE>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under this Plan, except where the context otherwise indicates, the
following definitions apply:
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) &#147;Administrator&#148; shall have the meaning set forth in Section&nbsp;3(a).
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) &#147;Affiliate&#148; means a corporation, partnership, business trust,
limited liability company or other form of business organization at least a
majority of the total combined voting power of all classes of stock or other
equity interests of which is owned by the Corporation, either directly or
indirectly, and any other entity designated by the Administrator in which the
Corporation has a significant interest.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) &#147;Award&#148; shall mean any stock option, stock appreciation right,
stock award, phantom stock award, or performance award.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) &#147;Board&#148; shall mean the Board of Directors of the Corporation.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) &#147;Code&#148; shall mean the Internal Revenue Code of 1986, as amended,
and any regulations promulgated thereunder.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) &#147;Common Stock&#148; shall mean shares of common stock of the
Corporation, $.01 par value.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) &#147;Corporation&#148; shall mean EntreMed, Inc. and any successor thereto.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) &#147;Exchange Act&#148; shall mean the Securities Exchange Act of 1934, as
amended.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) &#147;Fair Market Value&#148; of a share of the Corporation&#146;s Common Stock
for any purpose on a particular date shall mean the last reported sale price per
share of Common Stock, regular way, on such date or, in case no such sale takes
place on such date, the average of the closing bid and asked prices, regular
way, in either case as reported in the principal consolidated transaction
reporting system with respect to securities listed or admitted to trading on a
national securities
</FONT>
<P align="center"><FONT size="2">A-1</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<P><FONT size="2">exchange or included for quotation on the Nasdaq-National Market, or if the
Common Stock is not so listed or admitted to trading or included for quotation,
the last quoted price, or if the Common Stock is not so quoted, the average of
the high bid and low asked prices, regular way, in the over-the-counter market,
as reported by the National Association of Securities Dealers, Inc. Automated
Quotation System or, if such system is no longer in use, the principal other
automated quotations system that may then be in use or, if the Common Stock is
not quoted by any such organization, the average of the closing bid and asked
prices, regular way, as furnished by a professional market maker making a market
in the Common Stock as selected in good faith by the Administrator or by such
other source or sources as shall be selected in good faith by the Administrator.
If, as the case may be, the relevant date is not a trading day, the
determination shall be made as of the next preceding trading day. As used
herein, the term &#147;trading day&#148; shall mean a day on which public trading of
securities occurs and is reported in the principal consolidated reporting system
referred to above, or if the Common Stock is not listed or admitted to trading
on a national securities exchange or included for quotation on the
Nasdaq-National Market, any business day.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) &#147;Grant Agreement&#148; shall mean a written document memorializing the
terms and conditions of an Award granted pursuant to the Plan and shall
incorporate the terms of the Plan.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k) &#147;Participants&#148; shall have the meaning set forth in Section&nbsp;5.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l) &#147;Parent&#148; shall mean a corporation, whether nor or hereafter
existing, within the meaning of the definition of &#147;parent corporation&#148; provided
in Code section 424(e), or any successor thereto.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m) &#147;Performance Goals&#148; shall mean performance goals established by the
Administrator which may be based on one or more business criteria selected by
the Administrator that apply to an individual or group of individuals, a
business unit, or the Corporation and/or one or more of its Affiliates either
separately or together, over such performance period as the Administrator may
designate, including, but not limited to, business criteria based on operating
income, earnings or earnings growth, sales, return on assets, equity or
investment, regulatory compliance, satisfactory internal or external audits,
improvement of financial ratings, achievement of balance sheet or income
statement objectives, or any other objective goals established by the
Administrator, and may be absolute in their terms or measured against or in
relationship to other companies comparably, similarly or otherwise situated.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(n) &#147;Subsidiary&#148; and &#147;Subsidiaries&#148; shall mean only a corporation or
corporations, whether now or hereafter existing, within the meaning of the
definition of &#147;subsidiary corporation&#148; provided in section 424(f) of the Code,
or any successor thereto.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(o) &#147;Ten-Percent Stockholder&#148; shall mean a Participant who (applying
the rules of Code section 424(d)) owns stock possessing more than 10% of the
total combined voting power or value of all classes of stock or interests of the
Corporation or a Parent or Subsidiary of the Corporation.
</FONT>
<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR valign="top">
        <TD width="1%" align="left" nowrap><FONT size="2">3.</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="96%"><FONT size="2">ADMINISTRATION</FONT></TD>
</TR>
</TABLE>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Administration of the Plan. The Plan shall be administered by the
Board or by such committee or committees as may be appointed by the Board from
time to time (the Board,
</FONT>
<P align="center"><FONT size="2">A-2</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<P><FONT size="2">committee or committees hereinafter referred to as the &#147;Administrator&#148;).
Notwithstanding the foregoing, the Administrator may delegate to the Chief
Executive Officer of the Corporation the power to administer this Plan and have
the full authority of the Administrator hereunder with respect to Awards granted
to specified Participants or groups of Participants.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Powers of the Administrator. The Administrator shall have all the
powers vested in it by the terms of the Plan, such powers to include authority,
in its sole and absolute discretion, to grant Awards under the Plan, prescribe
Grant Agreements evidencing such Awards and establish programs for granting
Awards.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Administrator shall have full power and authority to take all other
actions necessary to carry out the purpose and intent of the Plan, including,
but not limited to, the authority to: (i)&nbsp;determine the eligible persons to
whom, and the time or times at which Awards shall be granted; (ii)&nbsp;determine the
types of Awards to be granted; (iii)&nbsp;determine the number of shares to be
covered by or used for reference purposes for each Award; (iv)&nbsp;impose such
terms, limitations, restrictions and conditions upon any such Award as the
Administrator shall deem appropriate, including, but not limited to, whether a
stock option shall be an incentive stock option or a nonqualified stock option,
any exceptions to nontransferability, any Performance Goals applicable to
Awards, any provisions relating to vesting, any circumstances in which the
Awards would terminate, the period during which Awards may be exercised, and the
period during which Awards shall be subject to restrictions; (v)&nbsp;modify, amend,
extend or renew outstanding Awards, accept the surrender of outstanding Awards
and substitute new Awards, or specify a lower or higher exercise price, or a
longer or shorter term, for any substituted Awards than the surrendered Awards,
or impose any other provisions that are authorized by this Plan (provided
however, that, except as provided in Section&nbsp;7(g)(i) of the Plan, any
modification that would materially adversely affect any outstanding Award shall
not be made without the consent of the holder); (vi)&nbsp;accelerate, extend, or
otherwise change the time in which an Award may be exercised or becomes payable
and to waive or accelerate the lapse, in whole or in part, of any restriction or
condition with respect to such Award, including, but not limited to, any
restriction or condition with respect to the vesting or exercisability of an
Award due to termination of any Participant&#146;s employment or other relationship
with the Corporation or an Affiliate; and (vii)&nbsp;establish objectives and
conditions, if any, for earning Awards and determining whether Awards will be
paid after the end of a performance period.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In making these determinations, the Administrator may take into account
the nature of the services rendered or to be rendered by the Award recipients,
their present and potential contributions to the success of the Corporation and
its Affiliates, and such other factors as the Administrator in its discretion
shall deem relevant. Subject to the provisions of the Plan, the Administrator
shall have full power and authority, in its sole and absolute discretion, to
administer and interpret the Plan and to adopt and interpret such rules,
regulations, agreements, guidelines and instruments for the administration of
the Plan and for the conduct of its business as the Administrator deems
necessary or advisable.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Non-Uniform Determinations. The Administrator&#146;s determinations
under the Plan (including, without limitation, determinations of the persons to
receive Awards, the form, amount and timing of such Awards, the terms and
provisions of such Awards and the Grant Agreements evidencing such Awards) need
not be uniform and may be made by the Administrator selectively among persons
who receive, or are eligible to receive, Awards under the Plan, whether or not
such persons are similarly situated.
</FONT>
<P align="center"><FONT size="2">A-3</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Limited Liability. To the maximum extent permitted by law, no
member of the Administrator shall be liable for any action taken or decision
made in good faith relating to the Plan or any Award thereunder.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Effect of Administrator&#146;s Decision. All actions taken and decisions
and determinations made by the Administrator on all matters relating to the Plan
pursuant to the powers vested in it hereunder shall be in the Administrator&#146;s
sole and absolute discretion and shall be conclusive and binding on all parties
concerned, including the Corporation, its stockholders, any Participants and any
other employee, consultant, or director of the Corporation, and their respective
successors in interest.
</FONT>
<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR valign="top">
        <TD width="1%" align="left" nowrap><FONT size="2">4.</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="96%"><FONT size="2">SHARES AVAILABLE FOR THE PLAN</FONT></TD>
</TR>
</TABLE>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Maximum Issuable Shares. Subject to adjustments as provided in
Section&nbsp;7(f), the shares of Common Stock that may be issued with respect to
Awards granted under the Plan shall not exceed an aggregate of 4,250,000 shares
of Common Stock. The Corporation shall reserve such number of shares for Awards
under the Plan, subject to adjustments as provided in Section&nbsp;7(f). If any
Award, or portion of an Award, under the Plan expires or terminates unexercised,
becomes unexercisable or is forfeited or otherwise terminated, surrendered or
canceled as to any shares, or if any shares of Common Stock are surrendered to
the Corporation in connection with any Award (whether or not such surrendered
shares were acquired pursuant to any Award), the shares subject to such Award
and the surrendered shares shall thereafter be available for further Awards
under the Plan; provided, however, that any such shares that are surrendered to
the Corporation in connection with any Award or that are otherwise forfeited
after issuance shall not be available for purchase pursuant to incentive stock
options intended to qualify under Code section 422.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Maximum Awards. Subject to adjustments as provided in Section&nbsp;7(f)
and Section&nbsp;7(g)(ii), the maximum number of shares of Common Stock subject to
Awards of any combination that may be granted during any three consecutive
calendar years of the Corporation (beginning in the calendar year of the
effective date of amendment number 1 to this Plan and not considering any years
prior thereto) to any one individual under this Plan shall be limited to
750,000.
</FONT>
<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR valign="top">
        <TD width="1%" align="left" nowrap><FONT size="2">5.</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="96%"><FONT size="2">PARTICIPATION</FONT></TD>
</TR>
</TABLE>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Participation in the Plan shall be open to all persons who are at the
time of the grant of an Award employees (including persons who may become
employees), officers, directors, and consultants of the Corporation, or of any
Affiliate of the Corporation, as may be selected by the Administrator from time
to time. A Participant who has been granted an Award may, if he or she is
otherwise eligible, be granted additional Awards if the Administrator so
determines.
</FONT>
<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR valign="top">
        <TD width="1%" align="left" nowrap><FONT size="2">6.</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="96%"><FONT size="2">AWARDS</FONT></TD>
</TR>
</TABLE>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Administrator, in its sole discretion, establishes the terms of all
Awards granted under the Plan. All Awards shall be subject to the terms and
conditions provided in the Grant Agreement.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Stock Options. The Administrator may from time to time grant to
eligible Participants Awards of incentive stock options as that term is defined
in Code section 422 or
</FONT>
<P align="center"><FONT size="2">A-4</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<P><FONT size="2">nonqualified stock options; provided, however, that Awards of incentive stock
options shall be limited to employees of the Corporation or of any Parent or
Subsidiary of the Corporation. Options intended to qualify as incentive stock
options under Code section 422 must have an exercise price at least equal to
Fair Market Value on the date of grant or at least 110% of Fair Market Value in
the case of a Ten-Percent Stockholder, but nonqualified stock options may be
granted with an exercise price less than Fair Market Value. No stock option
shall be an incentive stock option unless so designated by the Administrator at
the time of grant and such designation is reflected in the Grant Agreement
evidencing such stock option.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Stock Appreciation Rights. The Administrator may from time to time
grant to eligible Participants Awards of Stock Appreciation Rights (&#147;SARs&#148;). A
SAR may be exercised in whole or in part as provided in the applicable Grant
Agreement and entitles the Participant to receive, subject to the provisions of
the Plan and the Grant Agreement, a payment having an aggregate value equal to
the product of (i)&nbsp;the excess of (A)&nbsp;the Fair Market Value on the exercise date
of one share of Common Stock over (B)&nbsp;the base price per share specified in the
Grant Agreement, multiplied by (ii)&nbsp;the number of shares covered by the SAR, or
portion thereof, which is exercised. Payment by the Corporation of the amount
receivable upon any exercise of a SAR may be made by the delivery of Common
Stock or cash, or any combination of Common Stock and cash, as specified in the
Grant Agreement. If upon settlement of the exercise of a SAR a Participant is to
receive a portion of such payment in shares of Common Stock, the number of
shares shall be determined by dividing such portion by the Fair Market Value of
a share of Common Stock on the exercise date. No fractional shares shall be used
for such payment and the Administrator shall determine whether cash shall be
given in lieu of such fractional shares or whether such fractional shares shall
be eliminated.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Stock Awards. The Administrator may from time to time grant
restricted or unrestricted stock Awards to eligible Participants in such
amounts, on such terms and conditions (which terms and conditions may condition
the vesting or payment of Stock Awards on the achievement of one or more
Performance Goals), and for such considerations, including no consideration or
such minimum consideration as may be required by law, as it shall determine.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Phantom Stock. The Administrator may from time to time grant Awards
to eligible Participants denominated in stock-equivalent units (&#147;Phantom Stock&#148;)
in such amounts and on such terms and conditions as it shall determine, which
terms and conditions may condition the vesting or payment of Phantom Stock on
the achievement of one or more Performance Goals. Phantom Stock units granted to
a Participant shall be credited to a bookkeeping reserve account solely for
accounting purposes and shall not require a segregation of any of the
Corporation&#146;s assets. An Award of Phantom Stock may be settled in Common Stock,
in cash, or in a combination of Common Stock and cash, as specified in the Grant
Agreement. Except as otherwise provided in the applicable Grant Agreement, the
Participant shall not have the rights of a stockholder with respect to any
shares of Common Stock represented by a Phantom Stock unit solely as a result of
the grant of a Phantom Stock unit to the Participant.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Performance Awards. The Administrator may, in its discretion, grant
performance Awards, which become payable on account of attainment of one or more
Performance Goals established by the Administrator. Performance Awards may be
paid by the delivery of Common Stock or cash, or any combination of Common Stock
and cash, as specified in the Grant Agreement.
</FONT>
<P align="center"><FONT size="2">A-5</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR valign="top">
        <TD width="1%" align="left" nowrap><FONT size="2">7.</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="96%"><FONT size="2">MISCELLANEOUS</FONT></TD>
</TR>
</TABLE>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Investment Representations. The Administrator may require each
person acquiring shares of Common Stock pursuant to Awards hereunder to
represent to and agree with the Corporation in writing that such person is
acquiring the shares without a view to distribution thereof. The certificates
for such shares may include any legend that the Administrator deems appropriate
to reflect any restrictions on transfer. All certificates for shares issued
pursuant to the Plan shall be subject to such stock transfer orders and other
restrictions as the Administrator may deem advisable under the rules,
regulations and other requirements of the Securities and Exchange Commission,
any stock exchange upon which the Common Stock is then listed or interdealer
quotation system upon which the Common Stock is then quoted, and any applicable
federal or state securities laws. The Administrator may place a legend or
legends on any such certificates to make appropriate reference to such
restrictions.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Compliance with Securities Law. Each Award shall be subject to the
requirement that if, at any time, counsel to the Corporation shall determine
that the listing, registration or qualification of the shares subject to such an
Award upon any securities exchange or interdealer quotation system or under any
state or federal law, or the consent or approval of any governmental or
regulatory body, or that the disclosure of nonpublic information or the
satisfaction of any other condition is necessary in connection with the issuance
or purchase of shares under such an Award, such Award may not be exercised, in
whole or in part, unless such satisfaction of such condition shall have been
effected on conditions acceptable to the Administrator. Nothing herein shall be
deemed to require the Corporation to apply for or to obtain such listing,
registration or qualification, or to satisfy such condition.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Withholding of Taxes. Participants and holders of Awards shall pay
to the Corporation or its Affiliate, or make provision satisfactory to the
Administrator for payment of, any taxes required to be withheld in respect of
Awards under the Plan no later than the date of the event creating the tax
liability. The Corporation or its Affiliate may, to the extent permitted by law,
deduct any such tax obligations from any payment of any kind otherwise due to
the Participant or holder of an Award. In the event that payment to the
Corporation or its Affiliate of such tax obligations is made in shares of Common
Stock, such shares shall be valued at Fair Market Value on the applicable date
for such purposes.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Loans. The Corporation or its Affiliate may make or guarantee loans
to Participants to assist Participants in exercising Awards and satisfying any
withholding tax obligations.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Transferability. Except as otherwise determined by the
Administrator or provided in a Grant Agreement, no Award granted under the Plan
shall be transferable by a Participant except by will or the laws of descent and
distribution. Unless otherwise determined by the Administrator in accordance
with the provisions of the immediately preceding sentence, during the lifetime
of the Participant, the Award may be exercised only by the Participant or,
during the period the Participant is under a legal disability, by the
Participant&#146;s guardian or legal representative. Except as provided above, the
Award may not be assigned, transferred, pledged, hypothecated or disposed of in
any way (whether by operation of law or otherwise) and shall not be subject to
execution, attachment or similar process.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;Capital Adjustments. In the event of any change in the outstanding
Common Stock by reason of any stock dividend, split-up, stock split,
recapitalization, reclassification,
</FONT>
<P align="center"><FONT size="2">A-6</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<P><FONT size="2">combination or exchange of shares, merger, consolidation, liquidation or the
like, the Administrator may, in its discretion, provide for a substitution for
or adjustment in (i)&nbsp;the number and class of shares of Common Stock subject to
outstanding Awards, (ii)&nbsp;the exercise price of Stock Options and the base price
upon which payments under SARs are determined, (iii)&nbsp;the aggregate number and
class of Shares for which Awards thereafter may be made under this Plan, (iv)
the maximum number of shares of Common Stock with respect to which a Participant
may be granted Awards during the period specified in Section&nbsp;4(b) hereof.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;Modification, Substitution of Awards.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;Subject to the terms and conditions of this Plan, the
Administrator may modify the terms of any outstanding Awards; provided, however,
that no modification of an Award shall, without the consent of the Participant,
alter or impair any of the Participant&#146;s rights or obligations under such Award.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;Anything contained herein to the contrary
notwithstanding, Awards may, at the discretion of the Administrator, be granted
under this Plan in substitution for stock options and other awards covering
capital stock of another corporation which is merged into, consolidated with, or
all or a substantial portion of the property or stock of which is acquired by,
the Corporation or one of its Affiliates. The terms and conditions of the
substitute Awards so granted may vary from the terms and conditions set forth in
this Plan to such extent as the Administrator may deem appropriate in order to
conform, in whole or part, to the provisions of the awards in substitution for
which they are granted. Such substitute Awards granted hereunder shall not be
counted toward the limit imposed by Section&nbsp;4(b) hereof, except to the extent it
is determined by the Administrator that counting such Awards is required in
order for Awards hereunder to be eligible to qualify as &#147;performance-based
compensation&#148; within the meaning of Section&nbsp;162(m) of the Code.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;Foreign Employees. Without amendment of this Plan, the
Administrator may grant Awards to Participants who are subject to the laws of
foreign countries or jurisdictions on such terms and conditions different from
those specified in this Plan as may in the judgement of the Administrator be
necessary or desirable to foster and promote achievement of the purposes of this
Plan. The Administrator may make such modifications, amendments, procedures,
sub-plans and the like as may be necessary or advisable to comply with
provisions of laws of other countries or jurisdictions in which the Corporation
or any of its Affiliates operate or have employees.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;Termination, Amendment and Modification of the Plan. The Board may
amend, alter or terminate the Plan, or portion thereof, at any time.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)&nbsp;Non-Guarantee of Employment or Service. Nothing in the Plan or in
any Grant Agreement shall confer on an individual any legal or equitable right
against the Corporation, any Affiliate or the Administrator, except as expressly
provided in the Plan or the Grant Agreement. Nothing in the Plan or in any Grant
Agreement thereunder shall (i)&nbsp;constitute inducement, consideration, or contract
for employment or service between an individual and the Corporation or any
Affiliate; (ii)&nbsp;confer any right on an individual to continue in the service of
the Corporation or any Affiliate; or (iii)&nbsp;shall interfere in any way with the
right of the Corporation or any Affiliate to terminate such service at any time
with or without cause or notice, or to increase or decrease compensation for
such service.
</FONT>
<P align="center"><FONT size="2">A-7</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k)&nbsp;Other Employee Benefits. Except as to plans that by their terms
include such amounts as compensation, the amount of any compensation deemed to
be received by a Participant as a result of the exercise of an Award or the sale
of shares received upon such exercise will not constitute compensation with
respect to which any other employee benefits of such Participant are determined,
including, without limitation, benefits under any bonus, pension,
profit-sharing, life insurance or salary continuation plan, except as otherwise
specifically determined by the Administrator.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l)&nbsp;No Trust or Fund Created. Neither the Plan nor any Award shall
create or be construed to create a trust or separate fund of any kind or a
fiduciary relationship between the Corporation and a Participant or any other
person. To the extent that any Participant or other person acquires a right to
receive payments from the Corporation pursuant to an Award, such right shall be
no greater than the right of any unsecured general creditor of the Corporation.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m)&nbsp;Governing Law. The validity, construction and effect of the Plan,
of Grant Agreements entered into pursuant to the Plan, and of any rules,
regulations, determinations or decisions made by the Administrator relating to
the Plan or such Grant Agreements, and the rights of any and all persons having
or claiming to have any interest therein or thereunder, shall be determined
exclusively in accordance with applicable federal laws and the laws of the State
of Delaware without regard to its conflict of laws principles.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(n)&nbsp;Effective Date, Termination Date. The Plan is effective as of May
14, 2001, the date on which the Plan was adopted by the Board, subject to the
approval of the stockholders of the Corporation within twelve months of such
effective date. No Award shall be granted under the Plan after the close of
business on May&nbsp;14, 2011. Subject to other applicable provisions of the Plan,
all Awards made under the Plan prior to such termination of the Plan shall
remain in effect until such Awards have been satisfied or terminated in
accordance with the Plan and the terms of such Awards.
</FONT>
<P><FONT size="2">Approved by the Stockholders: June&nbsp;15, 2001<br>
Date Amendment No.&nbsp;1 Approved by Stockholders: June 6, 2002
<br>
Date Amendment No.&nbsp;2 Approved by Stockholders: June __, 2003
</FONT>

<P align="center"><FONT size="2">A-8</FONT>




<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<P align="center"><FONT size="2"><B>ANNUAL MEETING OF STOCKHOLDERS OF</B>
</FONT>

<P align="center"><FONT size="6"><B>ENTREMED, INC.</B>
</FONT>

<P align="center"><FONT size="2"><B>June&nbsp;18, 2003</B>
</FONT>


<P align="center"><FONT size="4">Please date, sign and mail<BR>
your proxy card in the<BR>
envelope provided as soon<BR>
as possible.
</FONT>
<P align="center"><FONT size="1"><font face=wingdings>&#226;</font> Please detach and mail in the envelope provided.<font face=wingdings>&#226;</font>
</FONT>
<p><br>
<P><Br>

<P>
<HR size="1" noshade>
<div align="center"><FONT size="1"><B>THIS PROXY IS SOLICITED ON
BEHALF OF  THE BOARD OF DIRECTORS OF ENTREMED, INC.<br>THE BOARD OF DIRECTORS
RECOMMENDS A VOTE &#147;FOR&#148; THE ELECTION OF DIRECTORS AND
&#147;FOR&#148; PROPOSALS 2 AND 3.<Br>
PLEASE SIGN, DATE AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE. PLEASE MARK
YOUR VOTE IN BLUE OR BLACK INK AS SHOWN HERE<FONT size="2"><font face=wingdings>&#253;</font></font></B>
</FONT></div>
<HR size="1" noshade>



<P><DIV style="float: left; width: 48%">
<P><br>
<p><br>
<P align="left"><FONT size="1">1.&nbsp;Election of Directors: Terms
Expiring 2006.
</FONT>
<DIV align="center">
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
    <TD width="18%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="22%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="1">&nbsp;</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD colspan="3" align="left" valign="top"><FONT size="1"><b>NOMINEES:</b></FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="1"><font face=wingdings>&#111;</font>&nbsp;<B>FOR ALL NOMINEES</B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="1">
<font face=wingdings>&#161;</font>
</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="1">Michael Tarnow</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="1"><font face=wingdings>&nbsp;</font>&nbsp;</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="1">
<font face=wingdings>&#161;</font>
</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="1">Ronald Capa</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="1"><font face=wingdings>&#111;</font> <B>WITHHOLD AUTHORITY<br>&nbsp;&nbsp;&nbsp;&nbsp;FOR ALL NOMINEES</B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>

<TD align="left" valign="top"><FONT size="1">&nbsp;
</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="1">&nbsp;</FONT></TD>
</TR>


<TR valign="bottom">
    <TD valign="top"><FONT size="1"><font face=wingdings>&nbsp;</font>&nbsp;</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="1">
&nbsp;
</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="1">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="1"><font face=wingdings>&#111;</font> <B>FOR ALL EXCEPT<bR></B>&nbsp;&nbsp;&nbsp;&nbsp;(See instructions below)</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="1">
&nbsp;
</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="1">&nbsp;</FONT></TD>
</TR>
</TABLE>
</DIV>

<DIV align="center">
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
    <TD width="18%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="77%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="1"><B><u>INSTRUCTION:</u></B></FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="1">
To withhold authority to vote for any individual nominee(s), mark
<B>&#147;FOR ALL EXCEPT&#148; </B>and fill in the circle next to each nominee you
wish to withhold, as shown here: <font face=wingdings>&#108;</font></FONT></TD>
</TR>
</TABLE>
</DIV>
<hr size="1" noshade>
<P><br>
<P><br>
<P><br>
<P><br>
<hr size="1" noshade>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR>
<TD><FONT size="1">To change the address on your account, please check the box at right and
indicate your new address in the address space above. Please note that changes
to the registered name(s) on the account may not be submitted via this method.
</FONT></TD>
<TD width="20%" align="center"><FONT size="4"><font face=wingdings>&#111;</font></font></TD>
</TR>
</TABLE>

<hr size="1" noshade>
</DIV>

<P>
<DIV style="float: right; width: 48%">

<P><TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR valign="top">
    <TD width="1%" nowrap align="right"><FONT size="1">&nbsp;</FONT></TD>
    <TD width="1%"><FONT size="1">&nbsp;</FONT></TD>
    <TD width="65%"><FONT size="1">&nbsp;</FONT></TD>
<TD></TD>
<TD align="center"><FONT size="1">FOR</FONT></TD>
<TD></TD>
<TD align="center"><FONT size="1">AGAINST</FONT></TD>
<TD></TD>
<TD align="center"><FONT size="1">ABSTAIN</FONT></TD>
</TR>

<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>
<TR>
    <TD nowrap align="right" valign="top"><FONT size="1">2.</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD><FONT size="1">Approval of amendments to the Company&#146;s 2001 Long-Term Incentive Plan described in the accompanying proxy statement.</FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><font face=wingdings>&#111;</font></TD>
<TD>&nbsp;</TD>
<TD align="center"><font face=wingdings>&#111;</font></TD>
<TD>&nbsp;</TD>
<TD align="center"><font face=wingdings>&#111;</font></TD>
</TR>

<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR valign="top">
    <TD width="1%" nowrap align="right"><FONT size="1">3.</FONT></TD>
    <TD width="1%"><FONT size="1">&nbsp;</FONT></TD>
    <TD><FONT size="1">Ratification of the appointment of Ernst &#38; Young LLP as independent auditors for the Company.</FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><font face=wingdings>&#111;</font></TD>
<TD>&nbsp;</TD>
<TD align="center"><font face=wingdings>&#111;</font></TD>
<TD>&nbsp;</TD>
<TD align="center"><font face=wingdings>&#111;</font></TD>
</TR>

<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR valign="top">
    <TD width="1%" nowrap align="right"><FONT size="1">4.</FONT></TD>
    <TD width="1%"><FONT size="1">&nbsp;</FONT></TD>
    <TD colspan="7"><FONT size="1">In their discretion upon such other business as may properly come before the meeting including any call for adjournment thereof.</FONT></TD>
</TR>
</TABLE>

<P align="left"><FONT size="2"><B>The shares of Common Stock represented by this proxy will be voted as directed. If no contrary instruction is given, the shares of Common Stock will be voted
for the election of the director nominees, for the approval of the amendments to the 2001 Long-Term Incentive Plan, and for the ratification of the appointment of Ernst &#38; Young LLP as the independent auditors of the Company.</B>
</FONT>

</DIV><!-- nbsp --><P>&nbsp;<BR clear="all">

<P align="left"><FONT size="1">Signature of Stockholder __________________&nbsp;&nbsp;&nbsp;Date: ________________&nbsp;&nbsp;&nbsp;Signature of Stockholder____________________&nbsp;&nbsp;&nbsp;Date: _________________&nbsp;&nbsp;&nbsp;
</FONT>

<DIV align="center">
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD valign="top"><FONT size="1"><B>Note:</B></FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="1">
Please sign  exactly as your name or names appear on this Proxy. When shares
are held jointly, each holder should sign. When signing as executor,
administrator, attorney, trustee or guardian, please give full title as such.
If the signer is a corporation, please sign full corporate name by duly
authorized officer, giving full title as such. If signer is a partnership,
please sign in partnership name by authorized person.</FONT></TD>
</TR>
<TR valign="bottom">
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="87%">&nbsp;</TD>
</TR>
</TABLE>
</DIV>



<P align="center"><FONT size="2">
</FONT>


<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<P>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
    <TD width="4%"><FONT size="1">&nbsp;</FONT></TD>
    <TD width="1%"><FONT size="1">&nbsp;</FONT></TD>
    <TD width="4%"><FONT size="1">&nbsp;</FONT></TD>
    <TD width="1%"><FONT size="1">&nbsp;</FONT></TD>
    <TD width="38%"><FONT size="1">&nbsp;</FONT></TD>
    <TD width="2%"><FONT size="1">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="1">&nbsp;</FONT></TD>
    <TD width="1%"><FONT size="1">&nbsp;</FONT></TD>
    <TD width="42%"><FONT size="1">&nbsp;</FONT></TD>
</TR>
<TR valign="bottom">
    <TD COLSPAN="5"><FONT size="1">ENTREMED, INC. ANNUAL MEETING TO BE HELD ON 06/18/03 AT 10:00 A.M. EDT</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD colspan="3"><FONT size="1">ENTREMED, INC.<br>06/18/03 AT 10:00 A.M. EDT</FONT></TD>
</TR>
<TR valign="bottom">
    <TD COLSPAN="6"><FONT size="1">FOR HOLDERS AS OF 04/28/03&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;* ISSUER CONFIRMATION COPY &#150; INFO ONLY *</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD valign="top"><FONT size="1">2 ITEMS</FONT></TD>
</TR>
<TR valign="bottom">
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD COLSPAN="3"><FONT size="1">THIS FORM IS PROVIDED FOR INFORMATIONAL<BR>PURPOSES ONLY. PLEASE DO NOT USE IT FOR<BR>VOTING PURPOSES.</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD VALIGN="TOP"><FONT size="1"><DIV ALIGN="CENTER"><u>DIRECTORS</u><BR>(MARK &#147;X&#148; FOR ONLY ONE BOX)</DIV></FONT></TD>
</TR>
<TR valign="bottom">
    <TD COLSPAN="5"><FONT size="1">CUSIP: 29382F103</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD valign="TOP"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD><FONT size="1"><B>FOR ALL NOMINEES</B></FONT></TD>
</TR>
<TR valign="bottom">
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD valign="TOP"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD><FONT size="1"><B>WITHHOLD ALL NOMINEES</B></FONT></TD>
</TR>
<TR valign="bottom">
    <TD valign="TOP" COLSPAN="5"><FONT size="1"><u>DIRECTORS</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CONTROL NO&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font face=wingdings>&#224;</font> 1<BR>DIRECTORS RECOMMEND: A VOTE FOR ELECTION OF THE FOLLOWING NOMINEES&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0010100<BR>1 - 01-MICHAEL TARNOW, 02-RONALD CAPE</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD valign="TOP"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD valign="top"><FONT size="1"><B>WITHHOLD AUTHORITY TO VOTE FOR<BR>ANY INDIVIDUAL NOMINEE. WRITE<br>NUMBER(S) OF NOMINEE(S) BELOW.</B></FONT></TD>
</TR>
<TR valign="bottom">
    <TD valign="TOP" COLSPAN="5"><FONT size="1">&nbsp;</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD valign="TOP" COLSPAN="3"><FONT size="1">&nbsp;<br>USE NUMBER ONLY &nbsp;__________________________</FONT></TD>
</TR>
</TABLE>

<P><DIV style="float: left; width: 48%">

<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">

<TR valign="bottom">
    <TD valign="top" colspan="2"><FONT size="1"><u>PROPOSALS:</u></FONT></TD>
    <TD align="center" valign="top"><FONT size="1">
DIRECTORS</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="1">&nbsp;</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD align="center" valign="top" nowrap><FONT size="1">
<u>RECOMMEND</u></FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="1">2&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD><FONT size="1">APPROVAL OF AMENDMENTS TO THE COMPANY&#146;S 2001 LONG-TERM INCENTIVE PLAN DESCRIBED IN THE ACCOMPANYING PROXY STATEMENT.</FONT></TD>
    <TD align="LEFT" valign="top" nowrap><FONT size="1">&nbsp;&nbsp;&nbsp;FOR &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font face=wingdings>&#224;</font> 2<br>&nbsp;&nbsp;0020702</FONT></TD>
</TR>
<TR valign="bottom">
    <TD width="5%">&nbsp;</TD>
    <TD width="75%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD width="5%">&nbsp;</TD>
    <TD width="75%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD width="5%">&nbsp;</TD>
    <TD width="75%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD width="5%">&nbsp;</TD>
    <TD width="75%">&nbsp;</TD>
    <TD width="20%"><FONT size="5">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top" NOWRAP><FONT size="1">3&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD><FONT size="1">RATIFICATION OF THE APPOINTMENT OF ERNST &#38; YOUNG LLP AS INDEPENDENT AUDITORS FOR THE COMPANY.</FONT></TD>
    <TD align="LEFT" valign="top" nowrap><FONT size="1">&nbsp;&nbsp;&nbsp;FOR &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font face=wingdings>&#224;</font> 3<br>&nbsp;&nbsp;0010200</FONT></TD>
</TR>
<TR valign="bottom">
    <TD width="5%">&nbsp;</TD>
    <TD width="75%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD width="5%">&nbsp;</TD>
    <TD width="75%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD width="5%">&nbsp;</TD>
    <TD width="75%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD width="5%">&nbsp;</TD>
    <TD width="75%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top" NOWRAP><FONT size="1">&nbsp;</FONT></TD>
    <TD><FONT size="1">*NOTE* SUCH OTHER BUSINESS AS MAY PROPERLY COME BEFORE THE MEETING OR ANY ADJOURNMENT THEREOF.</FONT></TD>
    <TD align="LEFT" valign="top" nowrap><FONT size="1">&nbsp;</FONT></TD>
</TR>
</TABLE>
</CENTER>

<P>&nbsp;
<P>&nbsp;
<P>&nbsp;
<P>&nbsp;
<P>&nbsp;
<P>&nbsp;
<P ALIGN="center">
<FONT size="1"><b>HOUSEHOLDING ELECTION</b></FONT>

<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR valign="top">
    <TD width="1%" align="left" nowrap><FONT size="1"><b>HH)</b></FONT></TD>
    <TD width="3%"><FONT size="1">&nbsp;</FONT></TD>
    <TD width="96%"><FONT size="1"><b>Mark &#147;FOR&#148; to enroll this account to receive certain future shareholder communications in a
single package per household. Mark &#147;AGAINST&#148; if you do not want to participate.

To change your election in the future, call 1-800-542-1061. See accompanying page for more information about this election.</b></FONT></TD>
</TR>
</TABLE>

</DIV>


<DIV style="float: right; width: 28%">

<P>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
    <TD width="97%"><FONT size="1">PLEASE INDICATE YOUR PROPOSAL SELECTION BY FIRMLY PLACING AN &#147;X&#148; IN THE
APPROPRIATE NUMBERED BOX WITH BLUE OR BLACK INK ONLY
</FONT></TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%" valign="middle"><FONT size="2"><font face=wingdings>&#253;</font></FONT></TD>
</TR>
</TABLE>

<P align="left"><FONT size="1">SEE VOTING INSTRUCTION NO <u>&nbsp;&nbsp;1&nbsp;&nbsp;</u> ON REVERSE
</FONT>
<P align="left"><FONT size="1">ACCOUNT NO:
</FONT>
<P align="left"><FONT size="1">CUSIP 29382F103
</FONT>
<P align="left"><FONT size="1">CONTROL NO:
</FONT>
<P align="left"><FONT size="1">CLIENT NO:
</FONT>
<P>&nbsp;
<P align="left"><img src="w86899dfadp.gif" alt="ADP LOGO">
<P>&nbsp;
<P align="left"><FONT size="1">51 MERCEDES WAY<BR>
EDGEWOOD NY 11717
</FONT>
<P>&nbsp;
<P>&nbsp;
<P align="left"><FONT size="1">IMPORTANT NOTICE REGARDING DELIVERY<BR>
OF SECURITY HOLDER DOCUMENTS (HH)<BR>
ENTREMED, INC.<BR>
9640 MEDICAL CENTER DRIVE<BR>
ROCKVILLE, MD 20850
</FONT>
<P>&nbsp;
<P align="left"><FONT size="1">_________________________/___<br>SIGNATURE(S)  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;DATE
</FONT>
</DIV>


<DIV style="float: right; width: 20%">

<P><TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR valign="top">
<TD align="center"><FONT size="1">FOR</FONT></TD>
<TD></TD>
<TD align="center"><FONT size="1">AGAINST</FONT></TD>
<TD></TD>
<TD align="center"><FONT size="1">ABSTAIN</FONT></TD>
</TR>

<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
</TR>
<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
</TR>
<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
</TR>
<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR valign="top">
<TD align="center"><FONT size="1">FOR</FONT></TD>
<TD></TD>
<TD align="center"><FONT size="1">AGAINST</FONT></TD>
<TD></TD>
<TD align="center"><FONT size="1">ABSTAIN</FONT></TD>
</TR>

<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
</TR>
<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
</TR>
<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
</TR>
<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR valign="top">
<TD align="center"><FONT size="1">FOR</FONT></TD>
<TD></TD>
<TD align="center"><FONT size="1">AGAINST</FONT></TD>
<TD></TD>
<TD align="center"><FONT size="1">ABSTAIN</FONT></TD>
</TR>

<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
</TR>
<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
</TR>
<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
</TR>
<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR valign="top">
<TD align="center"><FONT size="1">FOR</FONT></TD>
<TD></TD>
<TD align="center"><FONT size="1">AGAINST</FONT></TD>
<TD></TD>
<TD align="center"><FONT size="1">ABSTAIN</FONT></TD>
</TR>

<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
</TR>
<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
</TR>
<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
</TR>
<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR valign="top">
<TD align="center"><FONT size="1">FOR</FONT></TD>
<TD></TD>
<TD align="center"><FONT size="1">AGAINST</FONT></TD>
<TD></TD>
<TD align="center"><FONT size="1">ABSTAIN</FONT></TD>
</TR>

<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
</TR>
<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
</TR>
<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
</TR>
</TABLE>

<P align="left"><font face=wingdings size="1">&#223;</font> <FONT size="1">PAGE 1 OF 2
</FONT>

<P align="left">
<FONT size="1">FOLD AND DETACH HERE</FONT>
</DIV>
<!-- nbsp -->
<P>&nbsp;<BR clear="all">


<P align="center"><FONT size="1"></FONT>




<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<P><DIV style="float: left; width: 48%">

<P align="left"><FONT size="1">CUSIP
</FONT>
<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
    <TD width="45%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="50%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="1"><u>DIRECTORS</u></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="1">
CONTROL NO</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="4"><B>PLEASE RETAIN FOR<BR>
YOUR RECORDS</B>
</FONT>

<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
    <TD width="80%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="1"><u>PROPOSALS:</u></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD align="center" valign="top"><FONT size="1">
DIRECTORS</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="1">&nbsp;</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD align="center" valign="top" nowrap><FONT size="1">
<u>RECOMMEND</u></FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="1"><B>HOUSEHOLDING ELECTION</B>
</FONT>

<div align="left"><FONT size="1">This notice is appearing in this mailing on behalf of your Broker or Bank. In
December 2000, the Securities and Exchange Commission enacted a new rule that
allows multiple shareowners residing at the same address the convenience of
receiving a single copy of proxy and information statements, annual reports and
prospectuses if they consent to do so. This is known as &#147;Householding.&#148; Please
note that if you do not respond, Householding will start 60&nbsp;days after the
mailing of this notice. We will allow Householding only upon certain
conditions. Some of those conditions are:
</FONT></div>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR valign="top">
    <TD width="3%"><FONT size="1">&nbsp;</FONT></TD>
    <TD width="1%" align="left" nowrap><FONT size="1">&#149;</FONT></TD>
    <TD width="3%"><FONT size="1">&nbsp;</FONT></TD>
    <TD width="93%"><FONT size="1">The Issuer agrees to have its documents Householded,</FONT></TD>
</TR>

<TR valign="top">
    <TD width="3%"><FONT size="1">&nbsp;</FONT></TD>
    <TD width="1%" align="left" nowrap><FONT size="1">&#149;</FONT></TD>
    <TD width="3%"><FONT size="1">&nbsp;</FONT></TD>
    <TD width="93%"><FONT size="1">You agree to or do not object to the Householding of your materials,</FONT></TD>
</TR>

<TR valign="top">
    <TD width="3%"><FONT size="1">&nbsp;</FONT></TD>
    <TD width="1%" align="left" nowrap><FONT size="1">&#149;</FONT></TD>
    <TD width="3%"><FONT size="1">&nbsp;</FONT></TD>
    <TD width="93%"><FONT size="1">You have the same last name and exact address as another shareowner(s),</FONT></TD>
</TR>

<TR valign="top">
    <TD width="3%"><FONT size="1">&nbsp;</FONT></TD>
    <TD width="1%" align="left" nowrap><FONT size="1">&#149;</FONT></TD>
    <TD width="3%"><FONT size="1">&nbsp;</FONT></TD>
    <TD width="93%"><FONT size="1">Consistency with your Broker or Bank&#146;s practices.</FONT></TD>
</TR>
</TABLE>
<div align="left"><FONT size="1">If all of these conditions are met, and Securities and Exchange Commission
regulations allow, your household will receive a single copy of proxy and
information statements, annual reports and prospectuses.
</FONT></div>
<P align="left"><FONT size="1">The <b>HOUSEHOLDING ELECTION (HH)</b>, which appears on the accompanying voting form,
is not an issuer proposal. If you wish to participate in Householding, please
indicate &#147;FOR&#148; on the enclosed Voting Instruction Form and Householding will
begin immediately. If you do not wish to participate in the Householding of
investor communications, please indicate &#147;AGAINST.&#148; Your affirmative or implied
consent to Household will remain in effect until you revoke it by calling the
telephone number listed in the <b>HOUSEHOLDING ELECTION</b> paragraph. If you revoke
your Householding election, each primary account holder will begin receiving
individual copies within 30&nbsp;days of your revocation.
</FONT>
</DIV>

<DIV style="float: right; width: 28%">

<P align="left">
<FONT size="1">ENTREMED, INC.<BR>06/18/03 AT 10:00 A.M. EDT</FONT>

<P>&nbsp;
<P>&nbsp;
<P>&nbsp;
<P>&nbsp;
<P>&nbsp;

<P>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
    <TD width="97%"><FONT size="1">PLEASE INDICATE YOUR PROPOSAL SELECTION BY FIRMLY PLACING AN &#147;X&#148; IN THE
APPROPRIATE NUMBERED BOX WITH BLUE OR BLACK INK ONLY
</FONT></TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%" valign="middle"><FONT size="2"><font face=wingdings>&#253;</font></FONT></TD>
</TR>
</TABLE>

<P align="left"><FONT size="1">SEE VOTING INSTRUCTION NO <u>&nbsp;&nbsp;1&nbsp;&nbsp;</u> ON REVERSE
</FONT>
<P align="left"><FONT size="1">ACCOUNT NO:
</FONT>
<P align="left"><FONT size="1">CUSIP 29382F103
</FONT>
<P align="left"><FONT size="1">CONTROL NO:
</FONT>
<P align="left"><FONT size="1">CLIENT NO:
</FONT>
<P>&nbsp;
<P align="left"><img src="w86899dfadp.gif" alt="ADP LOGO">
<P>&nbsp;
<P align="left"><FONT size="1">51 MERCEDES WAY<BR>
EDGEWOOD NY 11717
</FONT>
<P>&nbsp;
<P>&nbsp;
<P align="left"><FONT size="1">IMPORTANT NOTICE REGARDING DELIVERY<BR>
OF SECURITY HOLDER DOCUMENTS (HH)<BR>
ENTREMED, INC.<BR>
9640 MEDICAL CENTER DRIVE<BR>
ROCKVILLE, MD 20850
</FONT>
<P>&nbsp;
<P align="left"><FONT size="1">_________________________/___<br>SIGNATURE(S)  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;DATE
</FONT>
</DIV>


<DIV style="float: right; width: 20%">

<P align="left">
<FONT size="1">FOLD AND DETACH HERE</FONT>
<br>
<font face=wingdings size="1">&#223;</font>

<P align="CENTER"><FONT size="1"><u>DIRECTORS</u><BR>
MARK &#147;X&#148; FOR ONLY ONE BOX:
</FONT>

<P align="left"><FONT size="2"><font face=wingdings>&#111;</font></FONT><br>
<FONT size="2"><font face=wingdings>&#111;</font></FONT><br>
<FONT size="2"><font face=wingdings>&#111;</font></FONT>

<P align="center"><FONT size="1">USE NUMBER ONLY
</FONT>

<P><TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR valign="top">
<TD align="center"><FONT size="1">FOR</FONT></TD>
<TD></TD>
<TD align="center"><FONT size="1">AGAINST</FONT></TD>
<TD></TD>
<TD align="center"><FONT size="1">ABSTAIN</FONT></TD>
</TR>

<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
</TR>
<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
</TR>
<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
</TR>
<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR valign="top">
<TD align="center"><FONT size="1">FOR</FONT></TD>
<TD></TD>
<TD align="center"><FONT size="1">AGAINST</FONT></TD>
<TD></TD>
<TD align="center"><FONT size="1">ABSTAIN</FONT></TD>
</TR>

<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
</TR>
<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
</TR>
<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
</TR>
<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR valign="top">
<TD align="center"><FONT size="1">FOR</FONT></TD>
<TD></TD>
<TD align="center"><FONT size="1">AGAINST</FONT></TD>
<TD></TD>
<TD align="center"><FONT size="1">ABSTAIN</FONT></TD>
</TR>

<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
</TR>
<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
</TR>
<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
</TR>
<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR valign="top">
<TD align="center"><FONT size="1">FOR</FONT></TD>
<TD></TD>
<TD align="center"><FONT size="1">AGAINST</FONT></TD>
<TD></TD>
<TD align="center"><FONT size="1">ABSTAIN</FONT></TD>
</TR>

<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
</TR>
<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
</TR>
<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
</TR>
<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR valign="top">
<TD align="center"><FONT size="1">FOR</FONT></TD>
<TD></TD>
<TD align="center"><FONT size="1">AGAINST</FONT></TD>
<TD></TD>
<TD align="center"><FONT size="1">ABSTAIN</FONT></TD>
</TR>

<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
</TR>
<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
</TR>
<TR><TD colspan="9"><FONT size="1">&nbsp;</FONT></TD></TR>

<TR>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
<TD>&nbsp;</TD>
<TD align="center"><FONT size="2"><font face=wingdings>&#111;</font></FONT></TD>
</TR>
</TABLE>

<P align="left"><font face=wingdings size="1">&#223;</font> <FONT size="1">PAGE 2 OF 2
</FONT>

<P align="left">
<FONT size="1">FOLD AND DETACH HERE</FONT>
</DIV>
<!-- nbsp -->
<P>&nbsp;<BR clear="all">

<P align="center"><FONT size="1"><b>DO NOT RETURN</b></FONT>

<P align="center"><FONT size="1"></FONT>




</BODY>
</HTML>

</TEXT>
</DOCUMENT>
